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Abstract 
The synthesis of isoflavonoid phytoalexins in legumes is relatively well understood, 
but far less is known about how these phytotoxic compounds are metabolised by the 
plant when no longer required. In this project medicarpin, the major isoflavonoid 
phytoalexin in alfalfa, was prepared in radiolabelled form and fed to cell cultures and 
seedlings of alfalfa. The metabolism of the radioactive phytoalexin was then studied by 
characterising the radiolabelled metabolites formed. Uptake of radiolabelled 
phytoalexin by cells was faster in elicitor-treated cultures than in untreated cultures. 
However, there was little difference in pattern or speed of metabolism in treated or 
untreated cultures. Labelled medicarpin was rapidly metabolised to a complex range of 
extractable medicarpin products (MPs). A very small proportion of the dose was 
broken down to ^^C02. A total of 8 MPs could be resolved as distinct metabolites by 
HPLC and TLC. However, as incubation time increased the radioactivity became 
associated with multiple minor components which could not be identified. The 8 MPs 
were characterised by UV and mass-spectrometry and where possible by co-
chromatography with authentic standards by TLC and HPLC. Four MPs were 
unambiguously identified as medicarpin-3-0-gluco.side-6"-0-malonate (MGM), the 
isoflavans vestitol and sativan and the pterocarpan 6a-hydroxy-3,4'-
dimethoxypterocarpan (variabilin). In addition a hydroxylated derivative of 
medicarpin, termed pseudomedicarpin was also tentatively identified. Of the four 
remaining metabolites MPl had a relative molecular mass of 166 but remained 
unidentified. M P l was formed from pseudomedicarpin, but could not be characterised 
due to its labile nature. Similarly MP3 and MP6 remained unidentified, though the 
evidence suggested that MPS was a demethylated product of medicarpin. The 
metabolism of medicarpin in seedlings resembled that of cell cultures with the exception 
that rather more of the medicarpin was conjugated to form MGM. 
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CHAPTER 1 
INTRODUCTION 
1.1 Phytoalexins 
Phytoalexins have been defined as "low molecular weight antimicrobial compounds that 
are both synthesised by and accumulate in plants after exposure to micro-organisms" 
[29]. This "working redefinition" was the product of a Nato Advanced Study Institute 
in 1980. As inducible metabolites, phytoalexins are distinct from the secondary 
products which accumulate constitutively in plants and which have also been implicated 
in disease resistance [78]. Phytoalexins are also distinct from the recently defined 
phytoanticipins, which represent preformed stores of defence compounds which are 
mobilised to form antifungal metabolites during plant-pathogen interactions [123]. The 
speed, intensity and inducibility of the phytoalexin response has facilitated biosynthetic 
studies of secondary products and has proved a useful model system for the study of 
differential gene expression in plants as it involves a characteristic, highly selective 
induction of specific host genes encoding the enzymes of phytoalexin synthesis [34, 
36]. 
1.1.2 The discovery of phytoalexins 
In the late 1930s Miiller and Borger observed that inoculation of potato tuber disks with 
an incompatible (avirulent) race of Phytopthora infestans resulted in protection against 
subsequent infection by a compatible (virulent) race. They postulated that chemicals 
produced by the potato cells during the incompatible interaction were able to block 
infection by the previously compatible race and termed these substances phytoalexins 
[34]. Twenty years later the inducible, antifungal phytoalexins rishitin and pisatin 
were characterised from infected potato and pea respectively [29]. These findings 
confirmed Miiller's hypothesis that phytoalexins are low molecular weight, broad 
spectrum, antimicrobial compounds which are synthesised by the host from distant 
precursors in response to microbial infection and which accumulate to sufficient 
concentration to limit microbial growth [34, 111]. 
1.1.3 Types and Classification of Phytoalexins 
Phytoalexins are derived from either the shikimate, acetate-polymalonate, shikimate-
polymalonate or terpenoid pathways or can be synthesised from a combination of these 
precursors [115]. Chorismic acid is required for the biosynthesis of anthraquinone 
phytoalexins and is a precursor of phenylalanine which is converted via 
phenylpropanoid intermediates to coumarin, isoflavonoid and stilbene phytoalexins. 
Acetyl-CoA gives rise to both malonyl CoA and mevalonic acid. Malonyl CoA is 
required for the biosynthesis of dihydrocoumarin, polyacetylene and isoflavonoid 
phytoalexins whilst mevalonic acid gives rise to sesquiterpenoid and triterpenoid 
phytoalexins. The isopentyl precursors of the terpenoids are also used in the 
biosynthesis of anthraquinone, coumarin and some isoflavonoid phytoalexins. From 
the complexity of the biosynthetic routes, it is evident, therefore, that the de novo 
synthesis of phytoalexins requires a highly co-ordinated biochemical response [130]. 
The majority of work has been carried out on phytoalexins from the Leguminosae and 
Solanaceae although they have also been found in the Convolvulaceae, Malvaceae, 
Vitaceae, Orchidaceae, Graminae and more recently in Coleostephus, Citrus, Sorghum 
and Cruciferae [70]. A striking feature of the approximately 300 known phytoalexins 
is their great structural diversity (see figure 1.1.3), which suggests they have evolved 
independenriy. 
1.1.4 ]VIode of action of phytoalexins 
Although there are many reports of the broad ranging toxicity of phytoalexins to 
prokaryotes and eukaryotes, there have been very few attempts to determine their mode 
(a) Anthroquinone (b) Coumarin 
R=-OH ,CH3,orOCH3 
(c) Furanoacetylene 
COOR 
Wyerone R=CH3 
Wyeronic acid R=H 
(e) Furanosesquiterpenoid 
Ipomeamarone R=CH2CH(CH3)2 
Ipomeamaronol R=CH2CH(CH3)CH20H 
(f) Isoflavonoid 
H O 
Coumestrol 
Umberlliferone 
(d) Furanocoumarin 
i 
Psoralen Ri,R2=H 
Xanthotoxin Ri=H,R2=OCH3 
Medicarpin Ri=H,R2=CH3 
PhaseoUidin Ri=CH2CH=C(CH3)2,R2=H 
Figure 1.1.3 An illustration of the structural diversity of phytoalexins. 
of action in organisms other than microbial pathogens. In part this is due to the 
difficulties in purifying sufficient amounts of completely pure phytoalexin to carry out 
significant toxicological experiments, particularly in studies of mammals. It has also 
been suggested that the lengthy extraction processes involved may subtly modify 
properties such as solubility [113]. 
Most of the available literature concentrates on interactions between phytoalexins and 
fungi. The variety of structures illustrated in figure 1.1.3 demonstrates that there is no 
obvious relationship between the chemical structure of the molecule and its antifungal 
activity. Effective doses of phytoalexins generally fall within the concentration range 
10'5-lO^M [110]. The toxicity of phytoalexins to fungi results in the inhibition of 
germ-tube elongation, mycelial growth and dry weight accumulation. The 
isoflavonoid, terpenoid and furanoacetylenic phytoalexins disrupt cytoplasmic 
streaming, cause granulation of the cytosol, disorganisation of the cell contents and 
breakdown of the cell membrane in fungal colonies [49, 124]. Although there is not 
enough conclusive evidence to define a precise mode of fungitoxic action for any 
phytoalexin, available evidence points towards the plasmalemma as being a major site 
of action [112], in a manner similar to established membranolytic agents, such as 
chloroform and Triton XI00. Typical damage includes swelling and bursting of the 
plasmalemma, which leads to leakage of electrolytes and metabolites and a reduction in 
mycelial dry weight [109]. Phytoalexins also disrupt the uptake of solutes as can be 
shown by the inhibition of the uptake of [U-l'^C]-glucose from the growth solution by 
R. solani in the presence of phaseollin [124], even though phaseollin had no 
appreciable effect on membrane ATPases [16]. Mycelia which had previously 
incorporated ^^C solutes also rapidly relea.sed containing material upon exposure 
to phaseollin suggesting that the plasma membrane was being disrupted [124]. 
Phytoalexins may also work by inhibiting fungal enzymes which degrade plant cell 
walls, preventing the fungus from spreading into surrounding tissues [18]. The mode 
of action of phytoalexins has also been investigated by studying the mechanisms which 
made some fungi resistant to their action. A well established basis for tolerance relies 
on the ability of fungi to detoxify phytoalexins (secdon 1.4.1) but cytological studies 
also indicate that the blockage of phytoalexin entry may contribute to tolerance. The 
amoeba Dictyostelium dicoideum can be induced to acquire a non-degradative 
resistance to pisatin, apparently through variations in membrane composition [69]. 
In addition to their fungitoxicity phytoalexins also have a marked effect on the viability 
of other plant pathogens. Isoflavonoid, flavonoid and furanoacetylenic phytoalexins 
appear to be selectively toxic to gram-negative bacteria [45] and investigations into the 
mode of action of phytoalexins on the root knot nematode demonstrated that glyceollin 
inhibited the motility of the serious legume pest Meloidogyne incognita but not of the 
related Meloidogyne javanica [68]. Glyceollin also inhibited oxygen uptake by 
Meloidogyne incognita, indicating an effect on respiration. Phytoalexins are also toxic 
to animals and it seems likely that this is due to membrane disruption. In some cases 
this toxicity is very pronounced with the isoflavonoid phaseollin killing brine shrimps 
at 2|ig/ml [5]. Several isoflavonoids have been shown to lyse red blood cells [99]. 
Ipomearone at concentrations of 1 to 4mM inhibited electron transport and oxidative 
phosphorylation in rat liver mitochondria, not by functioning as an uncoupler, but by 
inhibiting the electron transport chain [68]. In contrast higher concentrations of pisatin 
uncoupled rat liver mitochondria but Kaplan et al [68] speculated that lower levels 
would specifically inhibit the electron transport chain. Rotenone is also known to 
inhibit mitochondrial respiration by reducing both oxidative phosphorylation and the 
NADH reductase segment of the mitochondrial respiratory chain between NADH-
coenzyme A and NADH-cytochrome C [68]. 
An important and often overlooked fact is that not only are phytoalexins toxic to many 
pathogenic micro-organisms but they are usually equally toxic to the plants themselves. 
Several attempts have been made to examine the toxicity of phytoalexins to host plants, 
but the use of a) different experimental systems and b) very different concentrations of 
phytoalexins used in individual studies makes it hard to draw general conclusions about 
the mode(s) of action of phytoalexins in these circumstances. For example, Skipp et al 
reported that the isoflavonoid phaseollin disrupted the respiration of bean cell cultures 
[108] which lead to reduced growth of suspension cultures followed by cell death. 
VanEtten and Bateman reported that phaseollin had little effect on respiration in bean 
hypocotyl tissue, but caused a rapid release of ^6Rb+ from hypocotyl tissue into which 
^^Rb+ had previously been incorporated [124]. They put forward the hypothesis that 
phaseollin acted on the plasmamembrane or affected membrane function. Lyon and 
Mao reported that 100|.ig/ml phaseollin caused a rapid increase in the respiration rate of 
isolated tobacco protoplasts followed by a marked decrease, whereas SOOj-ig/ml rishitin 
only slightly affected the rate of respiration [86]. Glyceollin inhibited respiration in 
mitochondria isolated from soybean and beet (ED value 30}Ag/ml) but did not function 
as an uncoupler of oxidative phosphorylation, rather inhibiting the electron transport 
system some point after succinate dehydrogenase [68]. Since oxidative 
phosphorylation is dependent on mitochondrial membrane integrity and also no 
uncoupling was observed with glyceollin at concentrations that strongly inhibited the 
electron transport system, Kaplan et al concluded that the primary action of glyceollin 
is directly, and specifically, on a component of the electron transport chain rather than 
due to a general disruption of membrane integrity [68]. 
Sesquiterpene phytoalexins are also phytotoxic and rishitin has been shown to inhibit 
the germination of pollen from three Solarium species and to induce cell death and 
darkening in potato tuber slices. Rishitin also lysed isolated chloroplasts, although in 
this case the levels of phytoalexin used (300|.ig/ml) were higher than would be expected 
inplanta [85]. Detailed experiments investigating the effects of rishitin on liposomes 
indicated that rishitin acts on artificial membranes by directly increasing permeability to 
low molecular weight non-electrolytes [85]. The phytoalexin also increased the 
permeability of liposomes prepared without cholesterol, establishing that it was acting 
on the phospholipid and not the sterol components. Temperature had a small effect on 
rishitin or phytotuberin induced permeability changes in liposomes, with rishitin 
having a much greater effect than phytotuberin at all concentrations of the phytoalexin 
tested [85]. This is of particular interest as phytotuberin is less toxic than rishitin to 
plant cells, fungi and bacteria, therefore providing further support for the idea that the 
toxic effect of rishitin results from its disrupting effect on cell membrane fluidity. 
1.1.5 The elicitation of the phytoalexin response 
The induction of phytoalexin formation in plant tissues and cell cultures results from the 
perception by the plant cells of elicitor molecules [70], which may be of biotic or abiotic 
origin. The "hypersensitive response" is also elicited and is characterised by a series of 
physiological changes, including browning, callose formation, vascular blockage and 
phytoalexin accumulation, leading to necrosis of the tissues [34, 58, 90]. It is the 
incidence of cell death that separates the "hypersensitive response" from the 
"phytoalexin response". Biotic exogenous elicitors include polysaccharides, proteins, 
glycoproteins and unsaturated fatty acids [34] and are derived from structural 
components of pathogenic or non-pathogenic micro-organisms. Polysaccharide fungal 
elicitors are thought to interact with specific binding proteins at the plasma membrane, 
and following binding a signal is transmitted to the nucleus by a largely uncharacterised 
signal transduction system. This has been shown to be the case in soybean, where a 
heptaglucan elicitor, released from fungal cell walls by the action of p- ( l ,3 ) -
endoglucanase, binds selectively to a specific membrane receptor and elicits the 
accumulation of phytoalexins in soybean cell cultures [1, 135]. Endogenous elicitors, 
derived from the host plant cell walls and usually consisting of oligomers of pectin are 
also active in eliciting the phytoalexin response. These fractions are formed by the 
action of either plant or microbial hydrolases. Abiotic elicitors also cause the 
accumulation of phytoalexins and include the treatment of plants with UV light [96], 
heavy metal ions [57], glutathione[24], xenobiotics [117], mechanical wounding [2], 
freezing [4] and heating. In most cases these abiotic treatments appear to work by 
causing the release of endogenous elicitors. However, care must be taken when using 
these methods in biosynthetic studies, as they may work by initiating the release of 
phytoalexins from preformed stores rather than by de novo synthesis (see section 
1.4.2). Yoshikawa et al [136] also suggested that in the case of glyceollin production 
in soybean cotyledons, some abiotic elicitors do not stimulate the biosynthetic activity 
relative to the unelicited controls, but act by preventing phytoalexin degradation. 
1.1.6 Importance of Phytoalexins in Disease Resistance 
The disease resistance mechanisms present in plants can be divided into those which are 
present consutuUvely and those which are induced in response to infection [78]. 
Constitutive resistance consists of physical barriers to infection, such as the cutins, 
waxes and cell wall components, and preformed antifungal proteins and secondary 
products . Inducible resistance, which will be considered here, includes cell wall 
modification and the synthesis of antifungal hydrolases and PR proteins, in addition to 
the phytoalexin response [34, 98, 102]. It is increasingly clear that all of these induced 
defence mechanisms contribute to disease resistance and that phytoalexins are but one 
important component. Cell wall modification involves lignification, which provides a 
structural barrier to hyphal invasion of tissues and is associated with an activation of the 
phenylpropanoid pathway and the induction of peroxidases, which cross link the 
cinnamoyl alcohols. The production of hydroxyproline rich glycoproteins is also 
induced and these proteins are covalently cross linked into the wall, increasing 
resistance to degradation. PR proteins are usually defined as proteins of relatively low 
molecular weight (10-40kDa) which accumulate extracellularly in infected tissue and 
generally exhibit high resistance to proteolysis and have extreme isoelectric points. 
Some PR proteins have been identified as (3-(l-3)-glucanases and chitinases, which can 
hydrolyse the fungal cell walls, inhibiting further invasion [102]. The resulting fungal 
cell wall fragments can also serve as signals of pathogen invasion of the plant and 
trigger phytoalexin accumulation [136] (section 1.1.4). 
There is a large amount of circumstantial evidence describing the importance of 
phytoalexins in disease resistance in the available literature. In summary much work 
has been done to show that phytoalexins accumulate to fungitoxic concentrations during 
pathogen attack, that these phytoalexins are toxic to the fungi and that many virulent, 
but not avirulent pathogens can be shown to exclude or to metabolise phytoalexins. A 
more conclusive way to show that phytoalexins play an important role in plant defence 
is through the use of molecular genetics to show a) that the insertion of a phytoalexin 
detoxification gene into an avirulent fungus confers pathogenicity or b) that the ability 
of plants to synthesise novel phytoalexins confers resistance to disease. Both of these 
approaches have now been reported and confirm the importance of phytoalexins in 
disease resistance. Van Etten et al showed that when the maize pathogen Cochliobus 
heterotrophus was transformed with a gene encoding the phytoalexin degrading 
enzyme pisatin demethylase from Nectria haematococca (a virulent pathogen of pea) it 
became virulent on pea [106]. However, a saprophytic fungus Aspergillus nidulans, 
transformed with the same gene did not become virulent. The authors concluded that 
the high virulence observed in N. haematococca required several genes, one of which 
was the pisatin demethylase (pda) gene used in the transformation studies. Hain et al 
[55] reported that when a stilbene synthase gene isolated from grapevine was expressed 
in tobacco, the transgenic plant accumulated antifungal stilbenes and showed greater 
resistance to infection by Botrytis cinerea. In an alternative strategy, stereoisomers of 
the phytoalexins pisatin and maackiain which are not normally observed in legumes 
were shown to be more toxic to pea and clover pathogens in vitro due to their greater 
resistance to degradation [28]. This work suggests that transgenic plants engineered to 
produce non-host phytoalexins will display increased resistance to fungal pathogens. 
To further evaluate the significance of phytoalexins in plant disease resistance, 
quantitative knowledge of the exact spatial and temporal distribution of phytoalexins 
within plant tissue near infection sites is of great importance, i.e. it needs to be 
established that phytoalexins occur in the right place at the right time. A 
radioimmunoassay specific for glyceollin has been developed to quantitate the 
phytoalexin content in roots of soybean after infection with incompatible and 
compatible races of Phytophthora megasperma [50, 54, 95]. Fungal hyphae were 
detected by means of an immunofluorescent stain. The incompatible interaction 
resulted in fungal colonisation being limited to the area immediately surrounding the 
infection site. Glyceollin was shown to accumulate around hyphae to concentrations in 
excess of those needed to be inhibitory in vitro. In contrast, the compatible reaction 
was characterised by unchecked fungal colonisation of the root Steele, with minimal 
levels of glyceollin being detected. 
1.2 Isoflavonoid Phytoalexins 
1.2.1 The structure of isoflavonoids 
The isoflavonoids, which occur most notably in the Leguminosae are among the best 
characterised phytoalexins. There are over 600 known isoflavonoid structures 
including isoflavones, isoflavanones, rotenoids, pterocarpans, isoflavans and 
coumestans [31], of which the isoflavones form the largest group. 
Daidzein, 
Formononetin, 
Genistein, 
Biochanin A, 
^2 
Rl=R2=H 
Rl=H, R2=CH3 
Rl=OH, R2=H 
Rl=OH, R2=CH3 
Figure 1.2.1a The isoflavones 
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Figure 1.2.1a illustrates the four most common isoflavones out of over 200 known. 
The isoflavones are present as both inducible and constitutive metabolites in a number 
of legumes, accumulating both as the aglycones and the respective glucosides. 
Daidzein 7-O-glucoside (daidzin), Genistein 7-0-glucoside (genistin) and their 
respective 7,4'-di-0-glucosides are found in many of the leguminosae. Acylated 
glycoside derivatives such as formononetin 7-0-glucoside-6"-0-malonate may also be 
observed in plants such as alfalfa. 
Dihydrodaidzein, Ri=R2=H 
Dihydroformononetin Rl=H, R2=CH3 
Dihydrobiochanin A R i =OH, R2=CH3 
Figure 1.2.1b The isoflavanones 
Around fif ty isoflavanones (figure 1.2.1b) have been reported, most of which possess 
antifungal activity [132]. 
OCH, 
OCH, 
Figure 1.2.1c (i) Rotenoid 
skeleton 
(ii) Rotenone 
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Rotenoids (figure 1.2.1c) possess an additional carbon atom to the isoflavanones which 
is used to form a heterocyclic ring. There is no systematic nomenclature for these 
insecticidal compounds, but they are divided into subgroups by the level of oxidation of 
their ring system. Rotenone is typical in its isoprenyl substitution which adds a fifth 
heterocyclic ring. It is the most commonly found rotenoid [132]. 
(i) The 
pterocarpan 
skeleton 
Figure l,2.1d 
(ii) Medicarpin 
(iii) Pisatin 
Pterocarpans (figure 1.2.Id) also have a separate numbering system and are the second 
largest group of isoflavonoids. An ether linkage between the 4 and 2' positions results 
in the formation of a teffacylic ring structure. Most pterocarpans exhibit optical activity 
with the stereoisomers showing differential fungitoxicity [125]. Medicarpin is the most 
commonly found pterocarpan in nature. Like the rotenoids, pterocarpans are 
subdivided by means of their oxidation level. Pterocarpans represent the most reduced 
system, followed by the 6a-hydroxypterocarpans (e.g. pisatin) and finally the 
pterocarpenes [132]. 
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CH30 
Figure 1.2. le The isoflavan 
sativan 
Isoflavans (figure 1.2. le) are the most reduced form of isoflavonoid. These have been 
shown to interconvert with pterocarpans in planta [33] and the fact that all plant derived 
isoflavans possess a 2'oxygen substituent also suggests they can be made in vivo by 
pterocarpan reduction [132]. 
Figure 1.2.1f The 
Coumestan Coumestrol 
Coumestans (figure 1.2.If) represent the highest oxidation level for the isoflavonoid 
skeleton. They are easily recognisable by their bright blue fluorescence under UV light 
[132]. Coumestrol is the commonest coumestan found in legumes and is not 
fungitoxic. It is known to act as a natural oestrogen and has been implicated in the past 
with sterility in sheep feeding on clover containing high levels of coumestrol and other 
oestrogenic isoflavonoids [132]. 
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1.3 The biosynthesis of isoflavonoids in alfalfa 
The elicitation of isoflavonoid biosynthesis in cell cultures has made the phytoalexin 
response in legumes very amenable to study at both the biochemical and the genetic 
levels. The biosynthesis of medicarpin in alfalfa [13, 24, 25, 32, 33, 40, 91], 
medicarpin and maackiain in chickpea [6, 11, 26, 27, 66, 71], pisatin in pea [103] and 
glyceollin in soybean [19, 21, 47, 48] have been particularly well studied. In all cases 
the early stages of phytoalexin synthesis involve phenylpropanoid intermediates which 
are also used in the synthesis of lignin. The biosynthesis of medicarpin, the most 
widespread phytoalexin in the Leguminosae and the subject of this dissertation, is 
shown in figure 1.3. Phenylalanine, which is produced from the shikimate pathway is 
converted to cinnamic acid by the enzyme phenylalanine ammonia-lyase (PAL), the first 
committed step in the phenylpropanoid pathway. Cinnamic acid is then hydroxylated to 
p-coumaric acid (4-hydroxycinnamic acid) which can enter the phytoalexin pathway 
following esterification with Coenzyme A, catalysed by 4-coumarate: CoA ligase (4-
CL), to form chalcones following condensation with three malonyl CoA units as 
mediated by chalcone synthase (CHS). Chalcone isomerase (CHI) then catalyses the 
stereospecific isomerisation of a chalcone to its corresponding flavanone. Up to this 
stage of synthesis the pathway is also common to all branches of the flavonoid 
pathway. The aryl migration that generates isoflavones from flavanone precursors is 
catalysed by a cytochrome P450-dependent isoflavone synthase (IFS) which is unique 
to isoflavonoid synthesis. The next biosynthetic step, the methylation to produce 
formononetin, is still the subject of some uncertainty as daidzein is a poor precursor of 
medicarpin synthesis in alfalfa and clover [33] and the enzyme catalysing the 
methylation of the isoflavonoid methylates in the 7 rather than the 4' position [38]. 
However, it is clear that formononetin is an intermediate in the pathway in alfalfa as it 
accumulates constitutively as its conjugate formononetin 7-0-glucoside-6"-0-malonate 
(FGM) [121] and in feeding studies formononetin is an excellent precursor of 
medicarpin [33]. Formononetin is then hydroxylated in the 2' position by a 
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cytochrome P450 dependent isoflavone 2'-hydroxylase (IFOH) and 
2'hydroxyformonetin reduced to the isoflavanone vestitone by isoflavone reductase 
(IFR) prior to reductive ring closure to form the pterocarpan following the action of 
pterocarpan synthase (PTS). Pterocarpan synthase was believed to be a single enzyme, 
but it has recently been reported that the conversion of vestitone to medicarpin is 
catalysed firstly by vestitone reductase followed by 7,2'-dihydroxy-4'methoxy 
isoflavonol dehydratase [51]. The last two enzymic steps are stereospecific and give 
rise to the (-) isomer of medicarpin. 
1.3.1 The agricultural importance of alfalfa and its major 
pests 
Medicago sativa is the predominant forage legume crop in the world today. It is also 
the oldest cultivated fodder legume and was originally cultivated in Persia (Iran) and 
was then distributed through Europe, Asia, and the Americas by invading armies who 
planted the crop as forage for their horses [40]. It reached western Europe in the mid-
sixteenth century and because of the Spanish invasion of Central America was already 
used in Mexico by the end of the sixteenth century. It did not reach the UK until about 
1650 and surprisingly was completely unknown in North America until the middle of 
the nineteenth century where it was introduced from Mexico as "Chilean clover" and 
from Germany in hybrid form. In Australia alfalfa for sheep grazing is often grown on 
alkaline soils where other forage crops such as clover are not grown because they are 
more suited to acidic soils. However, it is in Northern America that alfalfa has become 
a major crop, initially in the South-Western states and later in the Northern states and 
Canada, with the introduction of winter-hardy varieties. 
Alfalfa is a cross-pollinating auto-tetraploid, which gives rise to considerable genetic 
variation such that even within a given cultivar isogenic lines are not available [40]. 
Alfalfa is either grown mixed with grasses or other legumes or in monoculture. The 
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seed is soaked in water prior to sowing and may be inoculated with Rhizobium meloliti 
to promote nodulation. Monocultured alfalfa is harvested by mowing after the first 
flowers have opened. This allows the crop to be cut again as growth is re-established 
throughout the season. Highest yields are obtained when the plants are grown under 
irrigation in hot climates. The alfalfa hay may be baled, used in silage, or pelleted 
before use as animal fodder. For human consumption either the fresh foliage or more 
usually young sprouts are used. 
Alfalfa is host to a wide range of potential fungal pathogens. These include 
Pseudopeziza, Leptosphaerulina and Stemphylium leaf spot diseases, Colletotrichum 
trifolii anthracnose, Fww/wm and Verticillium wilts and Phytophthora root rot [35]. 
In temperate areas, such as the UK Venicillium is the pest of major economic 
importance for alfalfa and investigations into compatible and incompatible interactions 
between this pathogen and its host have been going on for many years. In 1959 Isaac 
took a large number of Venicillium albo-atrum isolates from different hosts and 
showed that only those isolated from alfalfa were pathogenic to that plant [42]. This 
contrasts with most other Verticillium pathogens where each host plant is susceptible to 
isolates obtained from many different plants. Although Venicillium is normally 
regarded as a root infecting fungus, in alfalfa spread of the disease is mainly through 
aerial pans of the plant [42]. Using a combination of modem molecular techniques and 
more traditional plant breeding techniques there is potential for the development of new 
cultivars of alfalfa with improved disease resistance traits. Specific resistance genes 
can be introduced into alfalfa using both Agrobacterium tumefaciens and Agrobacterium 
rhizogenes [35]. However, the transformable cultivars are not suitable for field use, 
so outbreeding is required to introduce the transgene into commercially useful varieties. 
Another useful system for the fast screening of a lai'ge number of cultivars for disease 
resistance is to select for improved resistance traits arising in cell cultures from 
somaclonal variation, using Phyiopthora megasperma or Venicillium albo-atrum as the 
pathogens for testing [94]. The usefulness of the in vitro system stems from the 
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retention of resistance through the culturing procedure such that resistant cultures are 
derived from resistant plants and susceptible cultures are derived from susceptible 
plants. For resistance screening purposes either calli or suspension cultures can be 
used. Calli are inoculated with the pathogen and resistance is checked monitoring the 
hyphal development both inside and outside the callus. Alternatively, suspension 
cultures can be treated with filtrates from mycelial cultures of the fungus which contains 
toxins which inhibit cell growth and viability. Cells which are resistant to toxic filtrates 
may then be regenerated. Using these selection methods regenerants have been 
obtained possessing improved or modified resistance to VerticilUum albo-atrum [43]. 
The microscopic stem nematode Ditylenclus dipsaci is also a serious pest of alfalfa, 
particularly in western Europe, the USA and Canada. It attacks the stems and foliage 
of susceptible plants, which become stunted and distorted with swollen buds, shoots 
and stem bases. The only current, commercially practical control measures are to 
fumigate diseased seed with methyl bromide [53] or to use lines showing partial natural 
resistance [53]. Field infections start in small patches which slowly develop and in 
following years lead to reduced yields from early cuts of alfalfa hay. However, the 
deep root system and resulting drought resistance in alfalfa, coupled with the fact that 
Ditylenclus dipsaci is unsuited to warm temperatures often results in crop recovery. 
The root knot nematodes Meloidogyne are pests in warmer climates, particularly in the 
sandy soils of the southern and south-western states of the U.S.A., where alfalfa is 
particularly susceptible to Meloidogyne hapla. Resistant varieties are the cheapest and 
most effective means of control. Nevertheless as far back as 1980 it was calculated that 
in the USA nematode infestations resulted in an annual loss of 86 million dollars in lost 
alfalfa hay production [53]. In hot climates alfalfa is also prone to damage by insects, 
particularly plant hoppers and aphids which can cause severe losses in yield. 
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1.3.2 The phytoalexin response in alfalfa plants and cell 
cultures 
In terms of its relative concentration medicarpin is the major phytoalexin produced in 
both alfalfa plants and cell cultures. The phytoalexin response in alfalfa has been 
widely studied using a variety of systems, including both abiotic and biotic means of 
elicitation. Khan and Milton [74, 75, 76] investigated the interaction between 
Verticillium albo-atrum and alfalfa plants during infection, using a system of dropping 
a fungal spore suspension onto excised alfalfa leaves. They reported the presence of 
five phytoalexins in VerticilUum infected tissue, two of which were confirmed as being 
medicarpin and sativan and demonstrated that the differential pathogenicity of the fungal 
isolates tested was inversely related to phytoalexin production. 
Dewick and Martin provided much of the biochemical evidence for the biosynthetic 
pathways leading to medicarpin (figure 1.3.2) by feeding radiolabelled precursors to 
UV-irradiated or copper chloride treated alfalfa seedlings [32, 33, 91]. Extensive 
studies have also been carried out on gene expression and the induction of the 
biosynthetic enzymes involved in medicarpin synthesis using alfalfa calli and cell 
suspension cultures. Following treatment of alfalfa cell cultures with elicitors derived 
from fungal cell walls, HPLC analysis has shown that the predominant elicited product 
in cell suspension cultures is medicarpin with concentrations of up to 400nmol/g FW of 
the phytoalexin being obtained [24]. Medicarpin accumulated in both the cells and the 
medium and in some instances the total phytoalexin found extracellularly exceeded the 
amount of the compound found in the cells [72]. Labelling studies have shown that 
during fungal elicitation the majority of medicarpin was being fomied de novo, but 
there is also evidence that at least some of the phytoalexin is derived from the turnover 
o f M G M [40,73]. 
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Figure 1.3.2 The biosynthesis of medicarpin in alfalfa. PAL=Phenyl Ammonia-Lyase. 
CA4H=Cinnamic Acid 4 Hydroxylase. 4CL=4-Coumarate:CoA Ligase. CHS=Chalcone 
Synthase. CHI=Chalcone Isomerase. IFS=Isoflavone Synthase. IFMT=Isoflavone O-
Methyl Transferase. IFOH=Isoflavone 2'-Hydroxylase. IFR=Isoflavone Reductase, 
PTS=Pterocarpan Synthase (Vestitone reductase + 7,2'-dihydroxy-4'methoxy isoflavonol 
Dehydratase). 
The relative activities of a range of elicitor preparations, of both fungal and host origins 
were also tested by Dalkin et al [24]. In terms of extractable PAL activity an 
autoclaved cell wall preparation of the phytopathogenic fungus Colletotrichum 
lindemuthianum was the most effective elicitor preparation. Crude preparations of 
material released during autoclaving of alfalfa stems or leaves exhibited 30% of the 
activity obtained with the fungal elicitor. Mixtures of pectic fragments produced by 
acid hydrolysis of polygalacturonic acid or polymethylgalacturonic acid were less 
potent elicitors than the crude autoclaved leaf components. Fungal elicitation of alfalfa 
cell cultures resulted in large increases in the extractable activities of enzymes involved 
in the biosynthesis of medicarpin [24]. PAL, CA4H, and 4CL are common to the 
biosynthesis of all phenylpropanoid compounds whereas CHS and CHI are involved 
specifically in the formation of flavonoid and isoflavonoid precursors (figure 1.3.2) 
and daidzein-O-methyl transferase (DOMT) is specific for the isoflavonoid branch 
pathway leading to medicarpin. Enzymes were assayed up to 48h after elicitation and 
basal activities of all enzymes other than 4CL were found to be low relative to the 
maximum induced activities [24]. Differences were observed in the timing and level of 
maximum activity and the rate of decline of activity after the maximum. Induction of 
PAL, and particularly CA4H, was transient, whereas CHI and DOMT remained high 
48h after elicitation [24]. The authors concluded that, with the possible exception of 
4CL, the kinetics of enzyme induction were found to be consistent with a role for the 
enzyme increases in medicarpin synthesis, with the increases in CHS and DOMT 
activities of particular significance in view of their extremely low basal levels. 
Kessmann et al assayed the membrane-associated cytochrome P450 enzymes IS and 
IFOH, both of which were significantly induced by fungal elicitor [72]. It, therefore, 
appears that induction of pterocarpan biosynthesis in cultured alfalfa cells involves the 
induction of all the enzymes in the pathway from PAL onwards [72]. 
The changes in niRNA populations in elicited alfalfa cells were also examined by 
isolating polysomal mRNA at various times up to 48h post-elicitation. This mRNA 
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was then translated in vitro and the translation products analysed by 1- and 2-D gel 
electrophoresis [35] At least 15 distinct in vitro products were strongly up-regulated 
by elicitor treatment, including PAL and CHS subunits, plus several unidentified 
products [25]. 
These in vitro studies have been particularly useful in studying the importance of 
isoflavonoid phytoalexins in the defence response of alfalfa. A good correlation was 
established between the amount of medicarpin accumulating in calli infected with 
Verticillium albo-atrum and the inhibition of hyphal growth [79]. The resistance of the 
calli to the fungus could be abolished when the cells were grown on medium containing 
an inhibitor of phenylalanine synthesis such as glyphosate. It was also reported that 
increased temperature enhanced medicarpin accumulation and reduced hyphal 
colonisation [80]. As compared with plants, however, variations in the complement of 
phytoalexins produced have been observed during studies using cultured tissues. In 
work by Gustine and Moyer [52] and also Latunde-Dada and Lucas [79, 80], vestitol 
and sativan, which are both well characterised phytoalexins in alfalfa plants, were not 
observed in callus cultures challenged with blocks of fungal culture grown on agar, or 
using spore suspensions as inoculum. Elicitation of alfalfa with a fungal 
naphthoquinone [77] also resulted in a different profile of secondary product fomiation, 
with the isoflavone alfalone and a P-hydroxychalcone accumulating, but with an 
inhibition in pterocarpan production. 
1.4 The metabolism of isoflavonoid phytoalexins 
1.4.1 By Fungal Pathogens 
A great deal of work has been carried out on the metabolism of pterocarpan 
phytoalexins by phytopathogenic fungi and these reactions are summarised in fig. 1.4.1 
[125]. Successful invasion of the host plant may be dependent on the ability of a 
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fungal pathogen to carry out one or more of these reactions since the metabolites 
produced are reportedly less toxic to the pathogens [84, 89,125, 126] than the original 
phytoalexins [128]. 
One of the earliest cases to be studied in detail was the fungal metabolism of pisatin. It 
was first reported that Ascochyta pisi metabolised pisatin to unidentified products that 
were less toxic to the pisatin-sensitive fungus Glomerella cingulata [122]. Further 
work demonstrated that a number of pea pathogens could metabolise pisatin and the 
first step in this metabolism was shown to be the demethylation of the 3-0-methyl 
group (reaction 1, figure 1.4.1). However, the fact that Stemphylium botyrosum is 
sensitive to pisatin although it can metabolise it [125] demonstrates that in some cases 
fungi are still susceptible to phytoalexins even though they possess the ability to 
detoxify them. In the majority of cases, the inability to demethylate pisatin (a 
phenotype known as pda') results in the lack of ability to tolerate pisatin and a lack of 
pathogenicity. When pda' andpda"^ isolates of Nectria haematococca were crossed 
all of the progeny that were virulent on pea were pda'^ [128]. Six pda genes have 
been discovered to date and several pathogenic isolates of N. haematococca possess 
multiple copies of the pda genes. The enzyme pisatin demethylase (encoded by the pda 
gene) of Nectria haematococca is a microsomal cytochrome P450 monooxygenase 
(reaction 1, figure 1.4.1) catalysing the demethylation of pisatin to form the less toxic 
compound 6a-hydroxymaackiain [84]. These demethylases are encoded by any one of 
six pisatin demethylase {Pda ) genes. The Pda family of genes is meiotically unstable 
[93], a fact that may be exploited to investigate further the relationship between these 
genes and the pathogenicity oiN. haematococca. 
The metabolism of medicarpin and maackiain is illustrated in figure 1.4.1. Ascochyta 
rabiei performs four different initial reactions. In relation to figure 1.4.1 these include 
reductive cleavage of ring C (reaction 5), hydroxylation of ring A at the la position 
(reaction 3) and at another unknown position and 9-0-demethylation [60, 125]. The 
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enzyme responsible for the first reaction, the reductive cleavage of the pterocarpan to 
give the isoflavan, has been isolated from Ascochyta rabiei and is a soluble NADPH-
dependant reductase with a strong substrate affinity for medicarpin and maackiain [61]. 
Enzyme preparations from Ascochyta rabiei also catalysed the la hydroxylation and 9-
0-demethylation in vitro [125] with the la hydroxydienone observed m vitro but not 
in VIVO. The isoflavan product of reaction 5 is still fungitoxic but A. rabiei has been 
shown to break it down further to the non-toxic 2,4-dihydroxybenzoic acid via a 
stilbene intermediate [11]. The monooxygenase responsible for hydroxylation has also 
been purified and characterised from Ascochyta [119]. 
Nectria haematococca oxidises the pterocarpans using reactions 2,3, and 4 shown in 
figure 1.4.1 with the production of 6a-hydroxypterocarpans, la-hydroxydienones and 
isoflavans respectively [125]. It seems likely that all these reactions are catalysed by 
monooxygenases [125]. This has been demonstrated in the case of 6a-hydroxylation 
by the incorporation of ^^02 into the 6a-hydroxypterocarpan [125]. For both N. 
haematococca and A. rabiei a given isolate always performs the same set of reactions 
on medicarpin as on maackiain, except for the 9-O-demethylation which is only 
applicable for medicarpin. As a first step to evaluate the importance of the degradation 
of medicarpin and maackiain in determining the pathogenicity of A', haematococca on 
chickpea, 130 field isolates were examined [84]. Some could perform all three 
reactions, some one or two and some none at all. Al l isolates that produced the 
isoflavanones also produced the la-hydroxydienones, but the other detoxification 
reactions were carried out independently of one another and a positive correlation was 
shown between phytoalexin metabolism and pathogenicity. Three genes controlling 
maackiain metabolism have been identified in crosses among these field isolates [92]. 
MakI SindMak2 confer la-hydroxylation and/VfaM confers 6a-hydroxylation. MakI 
is closely linked to pda6 (encoding pisatin demethylase) and it is possible that a single 
gene encodes an enzyme that acts on both maackiain and pisatin [93]. Mak2 and Mak3 
segregate independently of the ability to demethylate pisatin demonstrating that the 
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enzymes encoded by these genes are specific for maackiain as well as for the position 
of hydroxylation. As with pda genes an isolate of N. haematococca must have at least 
one Mak gene to be highly virulent on pea. A number of other fungi are known to 
detoxify phytoalexins by demethylation. Pisatin, medicarpin and its methylated 
derivative 3,9-dimethoxypterocarpan have all been shown to be demethylated by 
Fiisarium proliferatum [11]. 
Higgins and Millar [59] compared the abilities of the alfalfa pathogen Semphylium 
botyrosum and the non-pathogen Helminthosporium turcicum to degrade the 
phytoalexins produced by alfalfa. They concluded that although both fungi elicited 
phytoalexin production, only S. botrysum had the ability to degrade these 
compounds. Ingham [64] demonstrated that Botrytis cinerea, Colletotrichum 
Undemuthanium and C. cojfeamim 6a-hydroxylate medicarpin in infected clover 
leaves. He also suggested that this may lead to further detoxification via 6a/ l la 
dehydration and oxidation of the resulting pterocarp-6a-ene to produce a non-antifungal 
coumestan. 
1.4.2 By Plants 
The accumulation of phytoalexins in alfalfa and other legumes in response to infection 
or elicitor treatment is well characterised, as is their metabolism by pathogenic fungi. 
However, studies with aseptic elicited cell cultures have demonstrated that not only 
these fungi, but also the host plants themselves can metabolise these compounds. For 
example, VanEtten and Bateman [124] demonstrated that when bean cell cultures were 
treated with phaseollin respiration was transientiy inhibited leading to reduced growth, 
but after a lag-period the cell cultures then recovered. Such behaviour is typical of cells 
metabolising a toxin to less toxic products [3]. The main aim of this thesis is to explore 
this latter option posed by Bailey [5] in the context of medicarpin metabolism in alfalfa. 
23 
This section is, therefore, a review of what is already known about the metabolism of 
phytoalexins by the host plants. 
As has been determined with a number of phenolic compounds one of the major routes 
of metabolism of isoflavonoid phytoalexins by the plants is conjugation with sugars 
and storage of glycosides in the vacuole [73]. Thus phenols, aromatic acids, 
flavonoids, steroids and many other constitutive secondary products are typically found 
as conjugates. Conjugation of secondary compounds alters the solubility, the 
biological activity and controls the transport through biological membranes. These 
reactions can, therefore, be seen as ways of temporarily storing or detoxifying 
unwanted material [62] and this has been shown to be the case with medicarpin 
conjugation in alfalfa. Synthesis of the phytoalexin during the elicitation response in 
plants and cell cultures was accompanied by an accumulation of medicarpin-3-0-
gIucoside-6"-0-malonate (MGM). In studies where L-[U-^4C]phenylalanine was fed 
to elicited cells, Kessmann et al [73] demonstrated that 16% of newly synthesised 
medicarpin was immediately glucosylated. MGM was also observed as a constitutive 
metabolite in healthy roots and cell cultures together with FGM. In the roots of healthy 
plants both these compounds accumulate as a function of age with plants inoculated 
with the nodule-forming Rhizobium meloliti containing lower levels of the conjugates 
than non-nodulated plants [73, 121]. FGM is of additional interest because recent 
reports have shown that following its exudation from the roots of nodulated plants 
FGM, but not formononetin has activity as an activator of nod genes in Rhizobium 
[23]. The malonyl glucosides of medicarpin and maackiain have also been shown to 
accumulate in chickpea cell suspension cultures [88]. 
Other recent work has also indicated that these conjugated stores of medicarpin and its 
precursor formononetin may play a more dynamic role in the metabolic regulation of 
isoflavonoid levels than had previously been recognised and should not be regarded 
merely as end point metabolites. In many conditions MGM and FGM may act as a 
24 
preformed store for medicarpin production. In feeding studies with [^^C]-
phenylalanine using the PAL inhibitor AOPP, elicited cells accumulated medicarpin 
with very low specific radioactivity, suggesting that it had come from the pre-
synthesised pools rather than being synthesised de novo [73, 87] This is also seen to 
happen in plants treated with abiotic elicitors such as copper chloride [88, 101]. 
Similarly, in chickpea Barz and Welle [11] found that low concentrations of elicitor 
favoured the turnover of MGM as a source of medicarpin while at higher concentrations 
of elicitor the medicarpin was synthesised de novo. 
The kinetics of disappearance of medicarpin in alfalfa cell cultures are very similar to 
those of their induction [73]. Given that glucosylation cannot alone account for the 
turnover of medicarpin in alfalfa the issue of other potential routes of metabolism 
becomes increasingly prominent. Barz suggested that the lack of obvious metabolites 
appearing as medicarpin and maackiain disappear implied that these compounds 
undergo extracellular peroxidative polymerisation in chickpea cell cultures [8] though 
no detailed evidence has been published to support this proposal. Although the 
catabolism of phytoalexins is undoubtedly more rapid in cell cultures than in plants 
[130] their detoxification may be important under field conditions. 
Recently, interest in the metabolism of medicarpin has been shown with respect to 
allelopathy in commercially grown alfalfa [37]. Alfalfa plants in autotoxic fields are 
dwarfed, spindly and yellowish and have few effective nodules. Medicarpin was 
found to be toxic to alfalfa seedlings, reducing seedling length by nearly 40% after 72 
hours. Interestingly, sativan and its methoxylated derivatives were not found to be 
autotoxic. Alfalfa seedlings were able to detoxify medicarpin in under 52h although the 
resulting products were not identified. 
There is little other work published on isoflavonoid phytoalexin metabolism in plants, 
but it is interesting to note the importance of hydroxylation in sesquiterpene 
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metabolism. For example, several attempts have been made to account for the 
disappearance of capsidiol when it is exogenously applied to pepper fruit. 13-hydroxy-
capsidiol and 9,10-dihydro-capsenone have been found in elicited and unelicited tissue 
fed with capsidiol respectively [116, 127, 131]. In vitro experiments with rabbit liver 
and pepper leaf microsomes suggest that a cytochrome P-450-dependent 
monooxygenase is responsible for the metabolism of capsidiol in pepper [104, 105]. 
There are several reports of metabolism of other sesquiterpene phytoalexins by 
cytochrome P-450-dependent monooxygenases including ipomeamarone (a 
furanosesquiterpene) from sweet potato and rishitin (a sesquiterpene) from potato. 
Significantiy, in tobacco cell cultures the metabolism of the sesquiterpene phytoalexin 
capsidiol was inhibited by elicitor treatment while the degradation of debneyol was 
unaffected [120]. 
In addition to enzymic degradation some phytoalexins are sufficiently labile to undergo 
spontaneous decomposition. The cotton phytoalexin desoxyhemigossypol can be 
shown to decompose rapidly in pH 6.3 phosphate buffer solution [114]. Addition of 
reducing agents ascorbic acid, reduced glutathione and cysteine greatly reduce this 
reaction, but EDTA has the opposite effect. Catalase also reduces this reaction. 
Stipanovic et al suggest that these results indicate free radical oxidation is the 
mechanism of decomposition of desoxyhemigossipol to form hemigossypol. 
1.5 Objectives of this project 
In addition to providing a summary of the available literature on the history, biological 
significance and biosynthesis of phytoalexins, this chapter has highlighted that the 
important gap in current knowledge is how the host plants protect themselves from 
these autotoxic compounds. In this project the metabolism of medicarpin has been 
investigated in both elicited and unelicited sterile alfalfa cell cultures and also in alfalfa 
seedlings. The primary aim of this project was to define the route(s) of metabolism of 
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medicarpin in alfalfa. The obvious lack of easily detectable metabolites in the literature, 
suggested that sensitive radiolabelled techniques would be needed to monitor 
metabolism. Therefore, using a variety of radiolabelled precursors, radiolabelled 
medicarpin was biosynthesised in alfalfa cell cultures and then extracted, purified and 
fed to seedlings and cell cultures for varying time intervals. The resulting metabolites 
were extracted, purified and identified by a variety of analytical techniques. 
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CHAPTER 2 
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Materials and Methods 
2.1 Sources of chemicals 
The biochemicals used were obtained from Sigma (Sigma Chemical company Ltd, 
Fancy Road, Poole, Dorset, BH17 7NH, England) or from BDH (BDH lab supplies, 
Poole, BH15 ITD, England). Cell culturing chemicals were purchased from Sigma or 
Oxoid (Unipath Ltd., Basingstoke, Hampshire, England) and flavonoids were supplied 
by Apin Fine Chemicals Ltd. (unit 29D, Milton Park, Nr. Abingdon, Oxon.). The 
inhibitor L-aminooxyphenyl propionic acid was obtained from Cambridge Research 
Biochemicals. Other inhibitors used were obtained from Sigma, with the exception of 
aminobenzotriazole which was kindly provided by Dr. David Cole of Rhone-Poulenc 
Agriculture Ltd., Ongar, Essex. 
2.2 Sources of radiochemicals 
Radiochemicals used were obtained from Amersham Life Science (Amersham 
International Pic, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA). L-
[U-14c]-phenylalanine (16.6 GBq/mmol, 450mCi/mmol), L-[ring-2,3,4,5,6-3H]-
phenylalanine (3.7-4.8TBq/mmol, 100-130Ci/mmol) and L-[methyl-3H]-methionine 
(2.6-3. ITBq/mmol, 70-85Ci/mmol) were each used as substrates for phytoalexin 
biosynthesis. 
2.3 Plant material 
Seeds of alfalfa (Medicago sativa L.) cultivars were obtained as follows: Europe and 
Euver from Elsom Seeds, Spalding, Links, UK; Vela from Dansk Planteforaedling 
A/S, Store Heddinge, Denmark and Vertus from Weibulls, Landskrona, Sweden. 
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Table 2.3.1 Contents of modified Shenk and Hildebrandt medium [31] 
Nutrient Molarity Stock (mg/1) Use (mg/1) 
K N O 3 2.5x10-2 101000 25 
MgS04 1.5x10-3 24640 15 
N H 4 H 2 P O 4 2.5x10-3 11500 25 
CaCl2.2H20 1.5x10-3 14680 15 
FeS04.7H20 5.4x10-3 1500 10 
Na2EDTA 5.4x10-5 2000 10 
Trace Elements 10 
Vitamins 2.5 10 
Kinetin 225 0.5 
2,-4D 186.6 2 
PCPA 10 
Myoinositol Ig 
Sucrose 30g 
Seeds of Essex red clover and Crimson clover were obtained from the Henry 
Doubleday Research Association, Coventry CVS 3LG, UK. Al l seeds were stored at 
4°C. When required seeds were sown in vermiculite and grown in growth chambers 
(23°C, 14h photoperiod, light intensity 165^mol m-^s"!). 
2.3.1 Plant cell culture 
Cell suspension cultures (50ml) were iniuated from callus and grown up in a sterile 
modified Shenk and Hildebrandt medium (table 2.3.1) in 250ml flasks in the dark, on a 
shaker at 130rpm at 25°C [72]. The cells were subcultured every 2-3 weeks when in 
stationary phase conditions using a 20% v/v inoculum under aseptic techniques in a 
laminar flow hood. 
2.4 Fungal material 
Isolates of the wilt-causing pathogen Verticillium albo-atrum which had been isolated 
from alfalfa grown in the field were generously donated by Dr John Lucas (University 
of Nottingham). The isolates were described as SWAV (a virulent pathovar of alfalfa), 
CDA234 (a less virulent pathovar) and HOP a pathogen of hops, but avirulent on 
alfalfa. 
2.4.1 Fungal Culture 
The isolates of Verticillium albo-atrum were maintained on Czapek-Dox agar (table 
2.4.1) and were maintained at 20°C in the dark. To subculture the fungi 1cm of agar 
was cut at the edge of the hyphal growth and placed upside down on fresh agar plates 
containing Czapek-Dox agar. Verticillium was grown in liquid Czapek-Dox medium 
adjusted to pH6.8 in 1 litre flasks to prepare elicitor. The medium was inoculated with 
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Table 2.4.1 Contents of Czapek-dox medium 
Nutrient g/1 Media 
Sodium Nitrate 2.0 
Potassium Chloride 0.5 
Magnesium glycerophosphate 0.5 
Ferrous sulphate 0.01 
Potassium sulphate 0.35 
Sucrose 30g 
the mycelial growth of Verticillium from one agar plate. The liquid cultures were 
maintained on an orbital shaker at 250C under ambient light for 14d prior to harvest. 
2.5. Preparation of elicitors 
2.5.1 The preparation of an elicitor from Verticillium albo-
atrum 
Elicitor was prepared from Verticillium albo-atrum using a method previously used for 
Colletotrichum lindemuthianum [56] Both the mycelia of the Verticillium and the 
media in which it is grown was used as a source of elicitor. Harvested cultures were 
centrifuged (12000g 40C, 30min) and the pellet and media processed separately. The 
pelleted material was extracted by stirring in 200ml of a 1:1 (v:v) methanol:chloroform 
mixture for five minutes at room temperature and then vacuum filtered through 
Whatman No. 1 filter paper. The residue was then sequentially washed with methanol 
(50ml) and acetone and allowed to dry overnight at room temperature. After 
homogenisation in a pestle and mortar, the mycelia was autoclaved with 100 v/w 
double disulled water for thirty minutes and vacuum filtered. The filtrate was 
centrifuged (lOOOOg, 15min, 40C) and the supernatant dialysed against double distilled 
water for twenty four hours at 40C prior to determination of reducing sugar content and 
testing for activity. 
For the preparation of elicitor from the culture medium an equal volume of ethanol was 
slowly added to the media and stirred overnight at 40C. The mixture was then 
centrifuged (lOOOOg, 15min, 40C) and the 50% pellet dried and stored at -20OC. The 
supernatant was then treated with an equal volume of ethanol to adjust it to 75% 
saturation and after stirring at 40C overnight the sample was recentrifuged. The 50% 
pellet, 75% pellet and final supernatant were stored at -20°C prior to determining sugar 
content and testing for activity. 
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2.5.2. The preparation of an elicitor from yeast. 
1kg of live baker's yeast was suspended in 1.5 1 of 20mM sodium citrate buffer (pH 
7.5) and autoclaved for 60min (1210C) [39]. It was then allowed to cool and 
centrifuged at 10 OOOg for 20min. The supernatant was then precipitated with 50% and 
75% ethanol as described for the Verticillium elicitor. The final pellet was taken up in 
distilled water and after checking the reducing sugar content stored in 1ml aliquots at 
-20°C, prior to testing for activity. 
2.5.3. Acid phenol assay for analysis of reducing sugar 
content 
A l l operations were carried out in the fume hood and a full face visor was worn. 25|il 
aqueous phenol (80%) were added to a 1ml sample of the elicitor preparation and 
mixed. 2.5ml concentrated H 2 S O 4 was then added and after cooling the samples were 
read at 490nm [44]. The concentration of glucose equivalents present was determined 
from a standard curve of D-glucose (0-100|ig/mI). 
2.6 Treatment of plant material with elicitors 
2.6.1 Elicitation of cell cultures 
Suspension-cultured cells in mid-logarithmic growth phase (5-7 days after subculture) 
were treated with elicitors derived from either Verticillium or yeast. 0.5ml yeast elicitor 
(corresponding to 100p.g glucose-equivalents of carbohydrate per ml of culture 
medium) or 0.5ml of Verticillium elicitor (corresponding to 70|ig glucose-equivalents 
of carbohydrate per ml of culture medium). Following incubation, cultures were 
harvested by vacuum filtration on \0\xM nylon mesh filters and the cells weighed and 
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frozen in liquid Nitrogen prior to storage at -80°C. The volume of the medium was 
noted prior to storage at -20*^C. For control treatments no additions were made to the 
cell cultures. 
2.6.2 Elicitation of seedlings 
Two systems of elicitation with copper chloride were used in seedling experiments. 
When seedlings were used as sources of isoflavonoids, seedlings were grown in 
vermiculite as described in Section 3.3. After 7 days they were watered daily with 
5mM copper chloride for 7 days and then roots and leaves harvested separately. In the 
case of hydroponic experiments 7 day old seedlings were gendy uprooted and placed in 
glass vials containing either 500|iM or 50|iM copper chloride and treated as required. 
After weighing plant material was stored at -80OC. 
2.7. Analysis of phytoalexin metabolites 
2.7.1. The extraction of plant tissue 
For the analysis of isoflavonoids fresh or frozen plant tissue was extracted in cold 
acetone (-20°C) to prevent hydrolysis of conjugates and peroxidative destruction of 
phenolics [39]. Ig of tissue was homogenised with 10ml of cold acetone in a pestle 
and mortar containing 0.5g acid washed sand and 20|il of Img/ml Biochanin A added 
as an internal standard to allow for correction for recoveries. After removing the 
solvent extract by vacuum filtration the residue was re-extracted with 10ml acetone 
followed by 10ml acetone:methanol (1:1 v/v). The filtrates were combined and after 
evaporating under vacuum taken up in HPLC grade methanol (1ml) prior to HPLC or 
TLC. I f further analysis was required the extract was taken to dryness in vacuo and 
the residue adjusted to pH8 with O.IM potassium phosphate buffer and partidoned 
twice with water-saturated ethyl acetate. After separation the organic phase was dried 
33 
with anhydrous sodium sulphate and concentrated for analysis by TLC. The aqueous 
phase was adjusted to pH2 and partitioned twice as before. Medicarpin and 
isoflavonoid aglycones would be expected to be found in the organic phase of the first 
partition and their malonylated glucosides in the organic fraction from the repartitioning 
in the presence of acid. 
2.7.2 Analysis of media and growth solution of seedlings 
Medium and seedling growth solution of known volume were extracted by partitioning 
twice with 2v/v water-saturated ethyl acetate [39]. Water was removed from the ethyl 
acetate using anhydrous sodium sulphate. The organic phase was then dried down 
under vacuum and redissolved in 1ml methanol prior to analysis. 
2.7.3 Hydrolysis of conjugates 
For conjugate hydrolysis the dried concentrated extracts from plant tissue or cell 
cultures was taken up in citrate-phosphate buffer (0.15M, pH5.2) containing Img/ml 
cellulase (from Trichoderma viridis, Boehringer Mannheim Uk Ltd, Bell Lane, Lewes, 
East Sussex) and incubated for 16h at room temperature [39]. Control treatments 
consisted of incubating the samples in citrate-phosphate buffer without cellulase. The 
hydrolysates were then analysed either directly by HPLC or following partitioning of 
the aglycones into an equal volume of ethyl acetate. In the latter case the ethyl acetate 
containing the aglycones was dried in vacuo and then the residue redissolved in 
methanol prior to HPLC or TLC. 
2.7.4 H P L C analysis and purification of isoflavonoids 
For analytical purposes an Apex C-18 reversed-phase column of dimensions 4 x 
250mm and particle size 5|a.m (Fisons chromatography, Loughborough, Leics, UK) 
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was used [39]. Al l .solvents were of HPLC grade and were filtered and degassed prior 
to use. Solvents used were solvent A (1% aqueous phosphoric acid) and solvent B 
(acetonitrile). The column was equilibrated with a mixture of solvent A: solvent B (8:2 
v/v) at a flow rate of 0.8ml/min. After injecting the clarified sample (20-100|il) the 
column was eluted at 0.8ml/min with increasing proportions of solvent B using a linear 
gradient such that at 45 minutes the solvent composition was solvent A: solvent B (4:6 
v/v). The eluant was monitored for UV absorbance depending on the absorption 
maximum of the products of interest (287nm for isoflavonoids, 345nm for 
coumestans). For preparadve purposes, a column of dimensions 150 x 10mm was 
used at with a flow rate of 2.5 ml/min. The products of interest were collected either 
manually whilst monitoring absorpnon changes or using an automatic fraction collector 
that collected at 1 minute intervals. 
2.7.5 T L C analysis 
Analytical TLC was used both to check the purity of isolated compounds and confirm 
their identities and preparative TLC was used to isolate compounds of interest. TLC 
plates (20x20cm) coated with silica gel containing fluorescent (F254) indicator (Merck, 
Darmstadt, Germany) were used with several solvent systems [39]. System 1; TEMPE 
(toluene, ethyl acetate, methanol and petroleum ether (6OOC-8OOC fraction), 6:4:1:3) 
and system 2; chloroform:methanol 98:2 (v/v) were used to resolve the isoflavonoids. 
The EFW solvent system (ethyl acetate, formic acid and water, 70:4:4) was used to 
separate and purify isoflavonoid glucosides and malonyl glucosides. Plates were 
viewed with a UV lamp at wavelengths of 300nm and 254nm to locate UV-absorbing 
and fluorescent metabolites. 
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2.7.6 Spectrophotometric analysis 
UV spectrophotometry was used to confirm the identity of isolated flavonoids by 
reference to their absorption spectra between the wavelengths of 200 and 350nm [64]. 
Absorbance spectra were determined for compounds dissolved in methanol. In some 
cases spectra were also examined with and without the addition of concentrated 
hydrochloric acid or 0. I M aqueous sodium hydroxide to test for pH dependent changes 
[65]. 
2.7.7 Mass Spectrometry 
Purified medicarpin and its metabolites were analysed by chemical ionisation and 
electron impact mass-spectrometry where possible. Mass Spectrometry analysis was 
kindly carried out and interpreted in collaboration with Dr. David O'Hagan from the 
Department of Chemistry at the University of Durham. 
2.8 The synthesis of radiolabelled phytoalexin. 
Three strategies were employed in the synthesis of radiolabelled medicarpin. L-
phenylalanine-[U-^4(;;:j (l6.6GBq/mmol, 450mCi/mmol), L-phenylalanine-[ring-3H] 
(3.7-4.8TBq/mmol, 100-130Ci/mmol) and L-[methyl-3H]-methionine (2.6-
3. ITBq/mmol, 70-85Ci/mmol) have each been utilised as precursors for phytoalexin 
synthesis in elicited cells. In the first instance, 7 flasks of suspension cells in mid-
logarithmic growth (50ml) were each treated with l . l l M B q of undiluted 14c-[U]-L-
phenylalanine and in the presence of yeast elicitor. The cells were incubated for 24h 
and the medium and cells collected separately after vacuum filtration through nylon 
mesh. 
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For studies with L-[3H-methyl]-methionine cell cultures were treated for 8h with 
elicitor followed by BOmin with 10|ig/ml cycloheximide and then 5ml was transferred 
to a sterile 40ml centrifuge tube containing 1.85 Mbq of undiluted L-[methyl-3H]-
methionine. After a further 2h incubation cells were harvested by centrifugation (900g, 
5min). 
In the final preparation of radiolabelled medicarpin 10 flasks of suspension cells were 
each treated with 3.7MBq of undiluted L-[U-3H]-phenylalanine and elicitor. The cells 
were incubated for 9h prior to harvest. 
The extraction and analytical techniques used with the radiolabelled phytoalexin were 
essentially the same as described in the previous section, with the addition that the 
recovery of total radioactivity was monitored at each stage by scintillation counting. 
Samples (0.1ml) were mixed with 4ml of "Ecoscint" scintillation fluid in a mini 
scintillation vial and the radioactive disintegrations per minute determined using a 
Canberra Packard 2000 CA Tri-Carb Liquid Scintillation analyser, operating with an 
external standard to correct for quenching. The incorporation of radiolabelled precursor 
into medicarpin was determined either by collecting fractions (Imin) from the HPLC 
eluant and determining the radioactivity present by scintillation counting or alternatively 
by locating the radioactive phytoalexin by autoradiography of TLC plates with X-ray 
f i lm (Fuji X-ray film). Radioactive isoflavonoids were purified by a combination of 
TLC and HPLC and the specific radioactivity of the pure compounds (Bq/mmol) 
calculated, after quantifying the amount of phytoalexin present by HPLC and the 
radioactivity by liquid scintillation counting. 
2.9 Metabolism studies with radiolabelled medicarpin 
Pure, radiolabelled phytoalexin was fed to elicited and unelicited cell cultures for 
various times and also to 10 day old seedlings. In feeding studies with cell cultures 
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50ml of cells previously treated for 8h with or without fungal elicitor were harvested by 
centrifugation (900g, 5min) and then resuspended in fresh sterile medium (50ml). 
After a further wash with fresh medium 2ml batches of cultures were incubated with 
13nmol [l^C-phenylalaninej-labelled medicarpin (8Bq/nmol), 30nmol [^H-methyl]-
labelled medicarpin (17Bq/nmol) or 179nmol [3H-phenylalanine]-labelled medicarpin 
(9Bq/nmol). To determine the administered dose and confirm chemical stability the 
radiolabelled phytoalexin was also added to either fresh or conditioned sterile medium 
without any cells present. Cells were harvested by centrifugation at timed intervals and 
the extracts analysed by HPLC, TLC and liquid scintillation counting. Medicarpin 
metabolites were purified by HPLC and TLC and analysed by a combination of UV-
spectroscopy, and electron-impact and chemical ionisation mass spectroscopy. Their 
identification was based on co-chromatography with available reference metabolites, 
comparisons with published chromatographic and published spectral data. 
2.10 Enzyme assays 
2.10.1 Determination of protein content 
The protein content in enzyme preparations was determined using a modification of the 
method of Bradford [17] with the kit provided by Bio-Rad. 2.7ml of Bio-Rad Assay 
Reagent previously diluted 1:5 with deionized water was mixed with 0.3ml of the test 
protein solution in a 3ml plastic cuvette. The colour was allowed to develop for five 
minutes and the absorbance detemiined at 595nm. The values obtained were compared 
to a standard curve prepared with known concentrations of BSA or bovine y-globulin. 
2.10.2 Phenylalanine ammonia lyase (PAL) 
The formation of cinnamic acid from L-phenylalanine was determined by measuring the 
increase in absorbance at 290nm [39]. Changes in absorbance not due to PAL were 
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corrected for by incubating the enzyme with D-phenylalanine, which is not a substrate 
for PAL. 
Cells were homogenised with acid-washed sand in a pestle and mortar in 1-2 v/w 
50mM Tris HCl pH 8.5 containing 2-mercaptoethanol(14mM) and 5% w/v PVP. After 
centrifugation (5000g, 2min), 0.1ml samples of the supernatant were incubated at 40OC 
with 0.9ml L-phenylalanine(12.1mM) in Tris-HCl(50mM) pH 8.5 with a parallel 
incubation of sample with 0.9ml 12.1mM D-phenylalanine serving as a control. The 
formation of cinnamic acid was followed by taking absorbance readings at 30min 
intervals in quartz cuvettes at 290nm up to 2h. PAL activity was calculated in |ikats/kg 
protein as: 
27780 X ( A A 290 L-Phe/60min- A A 290 D-Phe/6Qmin) 
|igs protein per incubation 
2.10.3 Peroxidase assays 
Frozen cells (Ig) were homogenised in a pestle and mortar in 4ml potassium phosphate 
buffer pH6 (O.IM) with 0.5g of acid-washed sand and a spatula of PVP [134]. After 
centrifugation (5000g, 2min) the cell free supernatant was assayed directiy and the 
pellet kept for analysis of cell wall peroxidases. The pellet was washed twice by 
resuspension in 2v/w phosphate buffer containing 1% v/v Triton XI00 to remove 
cytosolic contaminants and the detergent was then removed by washing the cell wall 
three times in phosphate buffer alone. The washed cell wall preparation was incubated 
in I M KCl for 20min with stirring at 4°C to solubilise ionically bound cell wall 
proteins. In all assays guaicol was used as a model peroxidase substrate. 0.88ml of 
potassium phosphate buffer (O.IM) was added to l()|il guaicol (89mM) and 100|il of 
sample in buffer in a 1ml cuvette. The reaction was initiated with 10|il hydrogen 
peroxide (O.IM) and after mixing the rate of formation of tetraguaicol was monitored 
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for 30s at 470nm. The enzyme was expressed as nkatals/mg protein after calculating 
the nmol of tetraguaicol fomied from its extinction coefficient. 
2.10.4 IVIethyl transferase assays. 
Plant cells were extracted in Iv/w 0.2M Tris/HCl buffer pH 7.5 containing 2-
mercaptoethanol (14mM), EDTA (5mM) and 5%w/v Dowex beads [39]. The extract 
was centrifuged (lOOOOg, 15min, 4 ^ 0 and adjusted to 80% saturation with respect to 
ammonium sulphate. After allowing the proteins to precipitate with gende stirring at 
4 0 c the suspension was centrifuged (lOOOOg, 15min, 40C). Prior to assay the pellet 
was redissolved in 0.2M Tris HCl pH 8.5 containing EDTA (5mM) in the absence of 
2-mercaptoethanol and desalted using a Pharmacia PD-10 Sephadex 025 column as 
recommended by the manufacturer. 
Medicarpin and formononetin were dissolved in dimethylsulphoxide at a concentration 
of lOmM and [ l ^ q - S A M (S-adenosyl-L-[14c-methyl]-methionine, 1.9GBq/mmol, 
Amersham International PLC, Amersham Place, Little Chalfont, Buckinghamshire, 
HP7 9NA) was prepared to a concentration of 30mM (8.33MBq/mmol). 50^il of the 
enzyme preparation was incubated with 5|il of the substrate and 5\il of [ ^ ^ Q - S A M for 
30min at 30OC and the reaction stopped by partitioning with 200|il ethyl acetate. 50^1 
aliquots of the organic and the aqueous phase were counted and the organic phase then 
dried down and analysed by HPLC and TLC, and radioactive metabolites identified by 
liquid scintillation counting of HPLC fractions and autoradiography respectively. 
2.10.5 Microsome assays. 
Two methods of microsome preparation were used [39]. The first method utilised 
ultracentrifugation to sediment the membrane fraction. 5g of tissue was homogenised 
in 5ml phosphate(O.lM) buffer pH 7.5 containing sucrose(0.4M), 2-
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mercaptoethanol(28mM) and 1.6g Dowex (prewashed in phosphate buffer) in an ice-
cold pestle and mortar with 5g acid-washed sand for 5-lOmin. The supernatant was 
decanted and the pestle rinsed out with a funher 3ml buffer. The combined extract was 
centrifuged (8000g, 15min, 40C). The supernatant was filtered through glass wool 
and the filter rinsed with buffer such that the final filtrate volume was 10ml. This was 
then centrifuged (135000g, 80min, 40C). After decanting the cytosol, the pellet was 
washed gently and blotted dry with filter paper. The microsomes were resuspended in 
0.5ml K Phosphate buffer(O.lM) pH 7.5 containing sucrose(0.4M) and 2-
mercaptoethanol(3.5mM) and either assayed directly or stored in 0.1ml lots at -70°C. 
The second method used for obtaining microsomes by-passed the use of the 
ultracentrifuge and relied upon magnesium precipitation of the ribosomes of the rough 
endoplasmic reticulum instead. The initial stages of this method were identical to those 
previously listed, but after filtration through the glass wool the filtrate was not 
centrifuged in the ultracentrifuge. It was, instead, adjusted to 50mM MgCl2 solution 
by the addition of I M MgCl2. The solution then was stirred for lOmin at 4°C and 
centrifuged (40000g, 30min, 4°C). The pellets were resuspended as described for the 
microsomes prepared by ultracentrifugation. 
Isoflavone 2' hydroxylase (IFOH) 
lOOjil of microsomal preparation was incubated with 330|il of K phosphate buffer pH8 
(0.3M) containing sucrose (0.4M), 150)il NADPH (20mM) and 20|il formononetin 
(2mM) in methanol at 30°C for 30-60 min [39]. After incubation the reaction mixture 
was partitioned twice with 0.6ml ethyl acetate (water-saturated) removing 0.45ml of the 
organic phase at each extraction. The ethyl acetate phase was taken to dryness and 
redissolved in 100|il of methanol. 20|il was analysed by HPLC at 248nm following 
calibrauon with a sample of 2'hydroxy formononetin, generously provided by Dr. 
R.A. Dixon, Noble Foundation, Ardmore, Oklahoma U.S.A. 
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C H A P T E R 3 
42 
T H E ACCUMULATION AND 
DISAPPEARANCE OF ISOFLAVONOIDS IN 
E L I C I T O R T R E A T E D ALFALFA. 
3.1 Introduction 
In vitro studies with suspension cell cultures and calli have been panicularly useful in 
determining the importance of isoflavonoid phytoalexins in the defence response in 
alfalfa. Latunde-dada and Lucas established a good correlation between the amount of 
medicarpin accumulating in calli infected with Verticillium albo-atrum and the 
restriction of hyphal growth [79]. Alfalfa is amenable to such studies as callus cultures 
can be readily initiated by germinating seeds on callus-inducing medium [79] and the 
cultures maintained on a simple modified Schenk and Hildebrandt medium [40]. 
Suspension cells can then be initiated by breaking up clumps of cells into the modified 
Schenk and Hildebrandt liquid medium and maintained in the dark at 250C on an orbital 
shaker. The typical growth cycle takes only 10-14 days, though the cells must be 
regularly established from callus (i.e. within 6 subcultures) to prevent the secondary 
product biosynthesis from becoming unreliable. When cells are kept under these 
conditions they produce a very similar range of compounds to those observed in 
healthy alfalfa roots, with the 6-0-malonyl glucosides of formononetin and medicarpin 
as the major constitutive metabolites in unelicited tissue [40, 73]. When treated with 
elicitors, medicarpin is the major elicited metabolite, with concentrations of up to 
400nmol/g fresh weight of cells being obtained in elicited cultures. Al l twelve enzymes 
involved in the biosynthesis of medicarpin have now been assayed [39, 51] in alfalfa 
cell suspension cultures and have been shown to be induced by elicitor treatment 
although they have not all been fully characterised. 
The profile of elicited products in cell culture appears to be simpler than that induced in 
elicited plants. For example, Gustine and Moyer reported that when callus cultures of 
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alfalfa were treated with mercuric chloride they synthesised medicarpin, but did not 
accumulate the isoflavans vestitol and sativan which are major metabolites m planta 
[52]. 
Studies by Kessmann et al [73] supported earlier studies [24] in determining that in 
elicitor-treated alfalfa cell cultures 50% of the medicarpin accumulated in the growth 
medium. Concentrations of medicarpin in alfalfa cultures reached maximal levels 24h 
after elicitor treatment and then rapidly declined, such that by 48h the phytoalexin was 
barely detectable. Labelling studies with [U-^^Cjphenylalanine showed incorporation 
into nine metabolites of which four could clearly be identified as FG, FGM, MGM and 
medicarpin. The remaining five metabolites cochromatographed with minor unknown 
UV absorbing fractions. Incorporation of label into isoflavonoid metabolites was 
greatest in cells treated with fungal elicitor and such cells rapidly accumulated radiolabel 
in medicarpin, which constituted the major radioactive isoflavonoid metabolite in 
elicited cells. The increase in medicarpin synthesis was accompanied by the 
accumulation of radiolabelled MGM, indicating that upto 16% of the newly synthesised 
medicarpin was being glucosylated. This data is also consistent with the idea that 
glucosylation only partially accounts for the turnover of medicarpin and that other 
route(s) exist which are as yet unknown. As discussed in Chapter 1 Barz et al have 
suggested that the disappearance of medicarpin in chickpea cell cultures may be due to 
extracellular peroxidative polymerisation [6, 11]. 
Kessmann et al [73] found that MGM accumulated in the period that free medicarpin 
was declining, suggesting that the phytoalexin was being actively glucosylated. 
However, the decline in medicarpin (800-320nmol/g fresh weight) was not 
accompanied by a directly corresponding increase in MGM (40-lOOnmol/g), suggesting 
that the disappearance of medicarpin could only be partially explained by the formation 
of the malonyl glucoside. The work described in this chapter concerns the 
optimalisation of the elicitation of medicarpin accumulation in alfalfa cell suspension 
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cultures and the determination of the rates of accumulation and disappearance of the 
phytoalexin in elicitor treated cultures. Another objective was to look for potential 
metabolites of medicarpin which accumulated during the period in which medicarpin 
declined. The experimental system was further characterised by studying the effect of 
elicitors on cytosolic and wall bound peroxidases which could have a role in 
phytoalexin degradation [6, 11]. Finally, preliminary metabolism studies were carried 
out by feeding coumestrol and formononetin to elicited and unelicited cell cultures to 
determine the capacity of alfalfa cells to detoxify isoflavonoids. 
3.2 The elicitation response in alfalfa cell cultures 
3.2.1 Introduction 
The first step in studying the metabolism of medicaipin in alfalfa involved establishing 
and characterising the phytoalexin response reviewed in section 1.1.5 in the cell 
cultures established at Durham. Cell wall derived elicitors were prepared from baker's 
yeast [107] and the fungal pathogen Verticillium albo-atrum for use with the cell 
cultures. 
3.2.2 Objectives 
Parameters of elicitation such as 1) the most effective dose of elicitor to use, 2) the type 
of elicitor to use, 3) optimal time after subculture for elicitor treatment and 4) effect of 
exposure time to elicitor were all examined to determine the optimal conditions for the 
induction of phytoalexins. These parameters are known to vary both between different 
cell lines and within different subcultures of the same cell lines and were, therefore, 
regularly checked throughout the three year programme, to maintain optimal elicitation 
and to minimise variation in the experimental system. 
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3.2.3 The effect of cell wall elicitors derived from 
Verticillium and yeast on alfalfa cell cultures. 
Methods 
Suspension cultures (variety Vela) in mid-logarithmic growth phase were treated with 
either yeast or Verticillium elicitor for 12h and analysed for PAL activity. The 
phytoalexin content of the cells and medium was also determined. 
Results 
As can be seen from table 3.2.3, the highest total concentrations of medicarpin in the 
combined cells and medium were achieved using 70|j.g GE of elicitor prepared from 
Verticillium, with levels being increased 19 fold in relation to untreated cells. PAL 
activity was also greatest in these cells, although it is possible that this may not have 
been the maximal activity as PAL is rapidly induced in alfalfa cell cultures and can peak 
around 4h [24], while in this study PAL activity was determined 12h after elicitor 
treatment. However, in cells treated with 140|ig GE of fungal elicitor, although PAL 
levels were nearly as high, levels of medicarpin and MGM were dramatically lower in 
the cells. Interestingly, medicarpin levels in the media were double those of the 70)ig 
GE treated cells. The yeast elicitor was used at a previously determined concentration 
for optimal elicitation and effectively induced the accumulation of free medicarpin in 
both the media and the cells. However, glucoside levels were very low (36nmol/g 
compared to 307nmol/g in cells treated with the Verticillium elicitor), resulting in the 
total medicarpin levels being lower than those obtained with the Verticillium elicitor. 
These results demonstrated that both the concentration and type of elicitor affect both 
the accumulation and metabolism of medicarpin in alfalfa and confirmed the need for 
strict standardisation of the method of elicitation. Figure 3.2.3 illustrates the difference 
in HPLC profile of metabolites achieved using the two different elicitors. 
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Table 3.2.3 PAL activity and phytoalexin content in 50ml alfalfa cell 
cultures treated for 12h with elicitors derived from Verticillium albo-
atrum and bakers' yeast. 
Elicitor i^g Pal acty M in M in cells M G M in total M 
G E / m l * (nkat/kg media (nmol/g) cells (nmol/ml 
protein) (nmol/ml) (nmol/g) +nmol/g) 
0 27 0.9-h/-0.1 10-H/-0.9 13 +/-0.6 23.9-H/-1.7 
70 (mycelial) 354 6.0 +/- 0.2 142+/- 12.8 307 +/-22.0 455-f-/-35 
140 (mycelial) 315 13.6 +/- 0.0 65 -f-/- 12.2 19 +/-3.0 97 +/- 15.2 
100 (yeast) 289 8.2 +/- 0.8 167 - H / - 18.3 36-H/-4.6 211 +/-23.7 
*GE= Glucose Equivalents Values refer to means of dupUcate determinations +/- the 
variation in the replicates. 
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Figure 3.2.3. Isoflavonoids resolved by HPLC in extracts from 
cells of alfalfa cell cultures treated vith (i) yeast elicitor 
(lOOugGE/ml) and (ii) Verticillium elicitor (70ugGE/ml) 
Summary 
Taking into account the ease of preparation of yeast elicitor, relative to the preparation 
of elicitors from Verticillium albo-atrum, and also the fact that free medicarpin levels 
were highest in cells treated with the yeast elicitor it was decided to use the yeast elicitor 
in all further experiments. The preferential accumulation of the aglycone of the 
phytoalexin with this elicitor also facilitated the purification of large amounts of 
medicarpin in subsequent studies. 
3.2.4 Optimal time after subculture for elicitation 
Method 
At timed intervals after subculture cell cultures (var Vela) were treated for 8h with 
100|ig/ml GE of the yeast elicitor and the phytoalexin content determined as described 
in chapter 2. 
Results 
Analysis of the medicarpin content in the ceils demonstrated that the best time to elicit 
Vela cells was 8 days after subculture (table 3.2.4). In the 8 day old cells the yield of 
medicarpin in the elicited cells was six fold higher than the yield in 2 day old cells and 
at 132nmol/gFW, was considerably greater than that determined in the corresponding 
control cells (4nmol/gFW). 
Phytoalexin content was also determined in unelicited cell cultures, at various times 
after subculture mediciirpin levels remained negligible throughout (4nmol/g) and MGM 
levels stayed constant at around 5.7nmol/g fresh weight -f-V 1.3. In this study, MGM 
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Table 3.2.4 The accumulation of Medicarpin and MGM in the cells of 
alfalfa cell cultures treated for 8h with yeast elicitor at various times 
after subculture. 
Days after subculture Medicarpin MGM 
(nmol/g FW) (nmol/g FW) 
2 22 64 
4 20 6 
6 110 41 
8 132 12 
12 48 10 
16 53 9 
accumulated most in cells elicited only 2 days after subculture, with levels remaining 
unaffected i f cells were elicited 4 days after subculture. 
Summary 
Optimal accumulation of the phytoalexin in elicitor treated alfalfa cell cultures occurred 
8 days after subculture. 
3.2.5 The optimal time after elicitation to harvest alfalfa 
cells 
IMethod 
8 day old cell cultures of alfalfa (var. Vela) were treated with yeast elicitor (100|ig 
GE/ml) and harvested 0, 1,2, 4, 8, 12, 24, 48, and 60h after elicitation. Cells and 
media were extracted and analysed as described in Chapter 2. 
Results 
Table 3.2.5 clearly demonstrates that the optimal time to harvest cells and media in 
terms of medicarpin yield was 8h after elicitation, with levels reaching 222nmol/g fresh 
weight in the cell extracts and 34nmol/ml in the media. A second peak of medicarpin 
accumulation was observed at 36h in the cells, but not in the medium and then levels 
declined sharply to 22nmol/g by 60h. 
The HPLC elution profile of isoflavonoid metabolites in control and elicitor-treated cells 
(figure 3.2.5a) and medium (figure 3.2.5b) clearly shows that medicarpin was the 
predominant elicitor-inducible metabolite in alfalfa cell cultures. 
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(i) Unelicited cells FGM MGM 
BiochaninA 
(ii) Elicited Cells Medicarpin BiochaninA MMt3M 
Figure 3.2.5a HPLC analysis of extracts fix>m (i) untreated 
cells and (ii) cells treated for 8h vith yeast elicitor 
BiochaninA vas used as an internal standard to correct for 
losses during extraction and is not an endogenous metabolite. 
HPLC traces are subject to scaling relative to the major UV 
absorbing peak for each run and therfore are not directly comparable. 
(i) Unelicited media 
(ii) Elicited media 
BiochaninA 
Medicarpin 
BiochaninA 
Figure 3.2.5b HPLC analysis of extracts from the medium of 
(i) untreated and (ii) ehcitor treated cell cultures (see figure 
3.2.5a for details). 
Table 3.2.5 Yields of medicarpin at various time intervals after 
elicitation. Values represent the means of duplicate determinations +/-
the variation in the duplicates. 
Time after elicitation (h) Medicarpin yield in cells Medicarpin 
nmol/g FW nmol/ml 
0 0 0 
2 38.2 +/-5.6 1.8 +/-0 
4 33.4 +/-0 3.9 +/-0 
8 221.9 +/- 18.3 33.8 +/-0.7 
12 165.1 +/- 35.3 30.5 +/- 8:7 
24 87 +/- 0 13+/-0 
36 130.1 +/- 33 4.2 +/- 0 
48 48.9 +/- 0 5+/- 1 
60 22+/- 17 7.4 +/- 2.3 
Summary 
The optimal time for harvesting elicited cells in terms of medicarpin yield was 8h. 
3.2.6 Conclusions from elicitation work 
From these studies a system of elicitation was established where cell cultures were set 
up from callus regularly (every six subcultures). Once cell suspension cultures had 
been established they were subcultured every 10-14 days, and when required were 
elicited 8 days after subculture for 8h. They were then harvested and cells stored at 
-80OC and media at -20^0 prior to analysis. 100|ig GE/ml elicitor prepared from yeast 
cell walls was used to elicit the phytoalexin response. Cell lines that were used, varied 
according to ease of maintenance of cell lines. Typically cultures derived from the 
varieries Euver or Vela were used as these reproducibly elicited high levels of 
medicarpin and grew quickly after subculture. 
3.3 The accumulation and disappearance of medicarpin and 
other elicited compounds in Medicago sativa (var. Europe) 
3.3.1 Objectives 
The main aim of this study was to determine the effect of elicitor treatment on the 
concentrations of elicitor-inducible UV-absorbing metabolites in suspension cultures of 
the cultivar Europe in an attempt to identify potential degradation products of the 
phytoalexin medicarpin. 
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3.3.2 Method 
At timed intervals phytoalexins were extracted from both cells and media 
(2,4,8,12,24,36,48 and 60h) after elicitor treatment. Isoflavonoid content was 
analysed by HPLC, individual UV-absorbing peaks being referred to by their retention 
times using the solvent system described in chapter 2. The kinetics of the appearance 
and disappearance of known and unknown elicited compounds were examined to try to 
identify likely metabolites of medicarpin. 
3.3.3 Results 
As compared with control cells medicarpin was clearly seen to accumulate in the 
elicitor-treated cells, with maximal induction occurring at 8h (222nmol/g compared to 
Onmol/g in unelicited cells) (figure 3.3.3a). Levels then declined sharply, although 
were are seen to rise again at 36h to 130nmol/g, before declining steadily to 22nmol/g 
at 60h. In this time course the levels of MGM were significantly higher than those 
observed in previous studies (tables 3.1.1 and 3.1.2). Contrary to the data produced by 
Kessmann at al [73]. the changes in the concentration of MGM could easily account 
for turnover of medicarpin, with levels rising as high as 837nmol/g in elicited cells 
compared to the levels in unelicited cells which remain constant at around 2-300nmol/g. 
However, the accumulation of MGM did not coincide with the disappearance of 
medicarpin. MGM did not accumulate to significant levels until 48h after elicitation, 
whereas medicarpin levels peaked at 8h. Therefore, MGM cannot be seen as a major 
route for the further metabolism of medicarpin. Interestingly, MGM levels actually 
declined in the early hours of the time course, as previously observed by Barz and 
Welle in chickpea [11] and Parry et al in alfalfa [101] suggesting that glucosides may 
be used as a source of phytoalexin at early time points in elicitation. FGM levels (fig 
3.3.3a) also peaked at 48h, perhaps acting as a sink for excess fomiononetin induced 
by elicitation. 
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Figure 3.3.3(a) The accumulation and disappearance of (i)medicarpin, 
(ii) MGM and (iii) FGM in alfalfa cell cultures following elicitor 
treatment. Data points represent the means of duplicate determinations 
with the error bars showing variation in the means. 
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Figure 3.3.3b The effect of elicitor treatment on the accumulation and disappearance of 
medicarpin and 10 other UV absorbing compounds, which eluted at various times during 
HPLC analysis. Data points represent the means of duplicate determinations with the 
error bars showing variation in the means. 
As determined by HPLC, in addition to MGM a number of UV absorbing compounds 
also underwent elicitor-dependent clianges (figure 3.3.3b). In addition to medicarpin, 
10 UV-absorbing compounds can clearly be seen to be induced. The relationship 
between these compounds, medicarpin and other isoflavonoids could not be 
unambiguously ascertained in such a study. However, compounds which accumulated 
while medicarpin disappeared were of particular interest as potential metabolites of 
medicarpin and other elicited isoflavonoids. Medicarpin levels peaked around 8h in the 
media as well as in the cells, so by comparing the times of maximal accumulation of the 
other 10 compounds it was possible to identify any potential metabolites. As identified 
in terms of retention time on the analytical HPLC column the metabolites eluting at 8, 
12, 15,16,18, 20 and 36 minutes all reached maximal levels at 8h and then declined. 
The compound eluting at 32 minutes peaked at 12h so could be a metabolite of 
medicarpin, while the 22 minute compound peaked at 36h, and is, therefore, unlikely to 
be a primary metabolite. The only compound to accumulate before medicarpin was the 
10 minute compound which, i f it is related, is more likely to be a precursor. A l l 
compounds accumulating at 8h showed similar kinetics of induction and disappearance 
to medicarpin, although the 15 minute compound had a more pronounced second peak 
at 36h than medicarpin. 
3.3.4 Conclusion 
These results suggested that with the exception of MGM and the 22 minute metabolite 
there were no clear cut candidate compounds in the medium whose induction kinetics 
matched decline in medicarpin i.e. likely metabolites of medicarpin. This could have 
been due to a number of reasons including (1) the metabolite(s) of medicarpin were not 
extracted during phytoalexin analysis; (2) they were present in such small quantities as 
multiple minor metabolites of medicarpin that they were not instantly recognisable as 
metabolites of medicarpin; or (3) they were present in the extracts but did not absorb 
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light at the wavelengths measured. These questions could only be resolved by utilising 
radiolabelled medicarpin in metabolism studies. 
3.4 The induction of enzymes during elicitation 
3.4.1 Phenylalanine ammonia-lyase (PAL) activity in elicitor 
treated cells 
Introduction 
Much work has been carried out on L-phenylalanine ammonia-lyase (PAL), the first 
committed step in phenylpropanoid synthesis due to its induction by a number of 
environmental stimuli such as elicitation, infection, UV light and wounding [34]. The 
enzyme is a tetramer and contains two active sites. In bean each subunit has a Mr of 
77000 Dalton [15]. In bean cell suspension cultures at least four forms of the active 
tetramer are observed, of identical Mr, but differing in isoelectric point. These forms 
exhibit different Km values with L-phenylalanine as substrate, and elicitor treatment of 
bean cell cultures results in a greater rehitive induction of the two forms with lowest 
Km value [15, 34]. The earliest demonstration of the de novo synthesis of PAL in 
bean cells induced by elicitor treatment was achieved using density labelling studies 
with 2h20 followed by analysis of the equilibrium distribution of enzyme activity on 
caesium chloride density gradients [34]. Further work demonstrated that, at high 
concentrations of Colletotrichum elicitor, PAL induction in bean was modulated by a 
dual control mechanism involving an increased rate of de novo synthesis coupled with 
inhibition of removal of enzyme [82]. Use of specific anti-(PAL) sera, in vivo pulse 
labelling experiments and in vitro translation analyses confirmed that PAL is indeed 
synthesised de novo in response to elicitor or fungal infection in a number of systems 
[34] Also, increased mRNA activity encoding PAL was observed in total cellular 
RNA, polysomal RNA and polyA+ RNA fractions [81] In situ RNA-RNA 
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hybridisation studies in juvenile potato leaves demonstrated the temporal and spatial 
differences in the accumulation of PAL mRNA that occurred as a response to fungal 
infection [97] [22]. PAL mRNA was rapidly elevated in interactions involving an 
incompatible race of the fungus, whereas a significanriy different profile accumulated in 
the compatible interaction. The infection site itself was not the site of maximal PAL 
activity, but the healthy as yet uninfected cells showed the marked increase in mRNA 
[97] during the incompatible response, which exhibited transient mRNA induction, 
peaking around 6h after infection. In the compatible interaction PAL messenger 
became progressively higher after inoculation and the site of mRNA was diffused 
throughout the tissue, rather than localised within the immediate zone of the infection 
site [97]. 
Bean and Parsley each contain families of three PAL genes [35] These genes encode 
distinct polypeptide isoforms in bean [35, 83]. The individual transcripts demonstrate 
different patterns of accumulation resulting in the selective synthesis of the 
corresponding enzyme in different biological situations. The complex patterns of PAL 
gene regulation and the apparent biochemical specialisation of the encoded 
isopolypeptides may be related to the highly diverse biological functions of 
phenylpropanoid natural products [35]. In common with bean, alfalfa also contains 
multiple elicitor-inducible isoenzymes of PAL [67] which are encoded by multiple 
genes [46]. 
Objective 
To show the elicitation of PAL activity in elicited alfalfa cell cultures, relative to 
unelicited controls. 
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Figure 3.4.1 The effect of elicitor on PAL specific enzyme activity. Data points 
represent the means of duplicate determinations with the error bars showing the 
variation in the replicates. 
IVIethod 
Cell cultures were harvested at various times after elicitor treatment, frozen directly in 
liquid nitrogen and subsequently assayed for PAL activity (section 2.10.2). 
Results 
The effect of elicitor-treatment on PAL activity is illustrated in figure 3.4.1. PAL 
specific activity increased following elicitation in comparison to the control, where no 
elicitation was evident. PAL specific activity was maximal at 4h, rising from 15|jJcat/kg 
protein to 66jikal/kg. Interestingly, there was also a second peak in PAL activity at 48h 
which was too late to account for the second rise in medicarpin but does correspond to 
the major peak in MGM and FGM levels (figure 3.3.3a). 
Summary 
This study confirmed the that PAL was indeed elicited when alfalfa cell cultures were 
treated with yeast elicitor. 
3.4.2 Peroxidase. 
Introduction 
Peroxidases catalyse a variety of different reactions in the metabolism of natural 
products. These include (1) oxidation of substrates with H 2 O 2 (peroxidase reactions), 
(2) introduction of oxygen into a substrate (oxygenase reaction), (3) electron transfer 
reactions (oxidase reactions), (4) transalkyhition and (5) halogenation reactions [7]-
The peroxidase-catalysed polymerisation reaction, suggested by Barz [6] as a potential 
mechanism for extracellular metabolism of medicarpin in chickpea cell cultures. 
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involves the formation of phenoxyradicals as an initial step. The unpaired electron of 
the phenoxy radical is stabilised by delocalisation throughout the molecule. These 
radicals can then either condense to form a polymer (for example, as in lignification) or 
react with H 2 O or oxygen to form higher oxidation products [6] . Such a 
polymerisation could be seen to be analogous to the formation of lignin, which is 
clearly catalysed by peroxidases. Polymerisation of lignin within the plant cell wall 
takes place after oxidation of the hydroxy-cinnamyl alcohols to mesomeric phenoxy-
radicals. The half life of these free radicals is very short before they react to give lignin 
and to form linkages between lignin and the polysaccharides of the wall [14]. 
Lignification is a well known plant defence response to pathogens, so peroxidases have 
been studied extensively in many plant-pathogen interactions [134]. 
There is also evidence that some phenolics may be metabolised by peroxidases in the 
cell vacuole in the presence of hydrogen peroxide. A basic peroxidase localised in 
vacuoles of mesophyll cells of Vicia faba was isolated (Mr 49,000) and shown to 
oxidise flavonols and flavonol glucosides which were contained in methanol extracts of 
the lower epidermis of Vicia faba leaves [118]. In cell cultures peroxidases can also be 
determined in medium. Thus, conditioned medium of cultured peanut cells has been 
used as a source of cationic and anionic peroxidases, which have subsequently been 
used in a number of structural studies [137]. Zheng et al demonstrated that peroxidase 
accumulating in the media had been synthesised in the cell and passed through the cell 
wall and that the isozymes extracted from the media displayed higher than 80% 
similarity to their corresponding isozymes from the cytoplasm and cell wall. 
Objective 
As peroxidases are found both extracellulariy as well as in soluble or bound forms in 
the cytoplasm, endoplasmic reticulum, tonoplast and cell walls [7], it was important to 
assay for these enzymes in several fractions from the cultures to determine their 
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Figure 3.4.2 Peroxidase activities in the (i)media, (ii)cell free extracts 
and (iii)cell wall extracts of cell cultures treated with and without elicitor. 
Data points represent the means of duplicate determinations with the error 
bars showing the variation in the replicates. 
potential importance in metabolising phytoalexins which are found both in the cells and 
the medium. 
IVIethod 
Guaicol was used as a model substrate to investigate the cellular distribution of 
peroxidase in control and elicited cell cultures. Peroxidase was assayed in elicitor-
treated alfalfa cell suspension cultures (variety Cal West) cells at the same time points as 
used for the PAL assays and the enzyme activity was determined in cell extracts, the 
media and the cell wall (see section 2.10.3). 
Results 
As illustrated in figure 3.4.2, in the media levels of peroxidase activity were similar in 
both elicited and unelicited cells, from the point of elicitation until between 24 and 36h 
when the levels in unelicited cells rose sharply. In the cell extracts, peroxidase levels 
were variable throughout the time course with no significant differences determined 
between control and elicited cultures suggesting that the variations observed were not 
elicitation dependent. The sharpest rise in activity was again between 48 and 60 hours, 
but unlike in the media, the increase was observed in both elicited and unelicited cells. 
In the extracts from the washed cell wall samples there was a dramatic difference in 
peroxidase activity towards guaicol, with a steady increase in activity in the elicited 
extracts peaking at 24h and then declining. 
Conclusion 
The results (figure 3.4.2) show that although the soluble cellular and extracellular 
specific activities of peroxidase remained unaltered by elicitation, significant induction 
of peroxidase occurred in the cell wall. This is known to happen for a variety of other 
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elicitable defence responses such as lignification, although it has not previously been 
shown in alfalfa. The crude peroxidase preparations from the cells, medium and cell 
wall were unable to degrade the medicarpin and are, therefore, unlikely to have a direct 
detoxification role. However, it was not possible to assess their potential role in 
polymerising medicarpin degradation products in view of the uncertain nature of these 
metabolites. 
3.5 Preliminary metabolism studies 
Introduction 
Chapter 4 describes the methods used to purify radiolabelled medicarpin from elicited 
cells. Medicarpin cannot easily be commercially obtained and to purify it successfully 
takes several time consuming steps. Since the phytoalexin precursor formononetin and 
the related coumestan phytoalexin, coumestrol can both be easily and cheaply obtained 
they provided a good basis for preliminary metabolism studies, to see i f any obvious 
metabolic routes could be determined using straight forward HPLC analysis. Both of 
these compounds are natural products in alfalfa and are closely related biosynthetically 
to medicarpin as described in .section 3.1. 
Objective 
The aim of these experiments was to assess the capacity of elicited and unelicited alfalfa 
cell cultures to metabolise exogenously applied coumestrol and formononetin over a 
20h time course. Coumestrol and formononetin were added at similar molarities to 
those typically seen for medicarpin under basal conditions and were added 8h after 
elicitation, the time point at which medicarpin turnover is highest. 
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IMethod 
Formononetin (2.3nmol/ml) and the coumestan phytoalexin coumestrol (2.4nmol/ml) 
were added to elicited (8h) and unelicited cell cultures and flasks were harvested at 
timed intervals. The coumestrol was obtained from Apin fine chemicals Ltd. (unit 29D, 
Milton Park, Nr. Abingdon, Oxon) and the formononetin was purified from the roots 
of elicited Essex Red clover seedlings. 
Results 
In both cases the isoflavonoids disappeared completely from the medium within lOmin. 
This disappearance resulted from active uptake by the cells as the isoflavonoids could 
be recovered quantitatively when incubated in conditioned medium or in heat-killed 
cells. As determined by HPLC there was no evidence of UV-absorbing metabolites 
accumulating to account for the disappearance of the isoflavonoids. 
Summary 
These experiments confimied that both control and elicited alfalfa cell cultures have the 
capacity to metabolise physiological concentrations of exogenously applied 
phytoalexins. In a later study coumestrol and formononetin were added in 
concentrations of 1 mg/ml, far higher than would be expected physiologically and there 
were still no identifiable metabolites. These results confirmed the need to carry out 
feeding studies with radiolabelled isoflavonoids. 
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CHAPTER 4 
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The Biosynthesis and Purification of 
Radiolabelled Medicarpin 
4.1 Introduction 
Radiolabelled isoflavonoids have previously been prepared in alfalfa plants and cell 
cultures using both radiolabelled isoflavone and chalcone precursors [32] and L-[U-
l^Cj-phenylalanine [73]. In the studies described here L-[ring-3H]-phenylalanine, L-
[U-l'^CJ-phenylalanine and L-[-^H-methyl]-methionine have been used to synthesise 
medicarpin labelled in either the aromatic ring or methoxy function. In the course of 
each biosynthesis the following analyses were made:-(i), the distribution of 
radioactivity between cells and extracellular media, (ii) the distribution between organic 
and aqueous phases during the cell and media extractions and (iii) the incorporation of 
precursor into medicarpin and related isoflavonoids. 
Figure 4.1 illustrates the different patterns of incorporation that can be achieved using 
different radiolabelled precursors. Phenylalanine, acetate and methionine can all be 
utilised to label different parts of the medicarpin molecule as shown. Both [^'^C]- and 
tritiated precursors have been used, [^H]- having the advantage that the compounds can 
generally be obtained at a higher specific activity, thus enabling the biosynthesis of 
phytoalexin with higher specific activity. This results in the production of more highly 
labelled compounds which should be easier to trace through metabolism, although 
tritiated compounds may not be so radiochemically stable due to the phenomenon of 
"tritium exchange." As the metabolic scheme in figure 4.1 demonstrates, phenylalanine 
is a distant precursor of medicarpin biosynthetically and a considerable amount of label 
may be lost before incorporation into the phytoalexin. Also phenylalanine is utilised in 
a variety of other biosynthetic pathways, not least protein synthesis and also in the 
formation of phenylpropanoid metabolites incorporated irreversibly into the cell wall as 
lignin. An advantage of using the L-[3H-niethyl]-methionine as a precursor is that the 
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Figure 4.1 The biosynthesis of medicar pm 
point in the isoflavonoid pathway at which the methyl group is incorporated via the 
isoflavone-O-methyl transferase (figure 4.1) is much nearer medicarpin than 
phenylalanine in terms of number of biosynthetic steps. To improve the incorporation 
of [^H-methyl]-methionine into secondary products the inhibitor cycloheximide was 
added prior to the label to prevent incorporation of the label into protein. This was 
hoped to enhance the biosynthesis of medicarpin. However, with the [^H-methyl]-
methionine label the resulting medicarpin would be side-chain labelled rather than ring 
labelled. This means that i f the first step medicarpin metabolism in alfalfa of the 
medicarpin was demethylation, as happens in some cases of fungal metabolism of 
phytoalexins (section 1.4.1), the radiolabel would be lost as methanol. The strategy of 
labelling the medicarpin molecule both in ring and side-chain positions maximises the 
chances of being able to follow the metabolic fate of medicarpin through a variety of 
pathways. 
4.2 The preparation of l ^ c ring labelled medicarpin from 
L-[U-14C]-phenylalanine 
4.2.1 Objective 
In the first preparation of radiolabelled medicarpin, L-[U-^4C]-phenylalanine was used 
as a precursor of phytoalexin synthesis. Since the major objective was to biosynthesise 
and purify medicarpin, only elicited cells were used and they were harvested at the time 
of maximal medicarpin accumulation as detemiined previously. 
4.2.2 iVIethod 
7x60ml flasks of alfalfa suspension-cultured cells (variety Europe) were each treated 
with 6.25mg yeast elicitor and 1.11 MBq L-[U-l'^C]-phenylalanine for 24h in the dark 
at 250c 7 days after subculture. Cells were harvested by vacuum filiation and washed 
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with SOml H2O before freezing in liquid Nitrogen and storing at -20OC. The medium 
was combined with the SOml wash and the cells were extracted with acetone and 
acetone and methanol using the polytron set at half speed. 
4.2.3 Results 
Suspension Cells 
4620q0000dpm [100%] 
Filter 
Cell extract (C) Medium (M) 
[19.4%] [19.0%] 
Figure 4.2.3a The distribution of radioactivity between cells and media. 
After separation aliquots of cell and media extracts were analysed for radioactivity 
content by liquid scintillation counting. Of the 4.62xl0^dpm applied to the cells 19.4% 
was recovered in the cells and 19.0% in the medium. Although not analysed at this 
stage, the remaining counts were likely to be lost via incorporation of phenylalanine 
into non-extractable components such as protein, lignin and polymerised non-
ethylacetate extractable compounds in the media or due to mineralisation to carbon 
dioxide. 
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Figure 4.2.3b Distribution of radioactivity during the extraction of 
isoflavonoids from labelled media. 
Figure 4.2.3b summarises the procedure utilised to extract labelled phenolic 
compounds from the extracellular media. After the media had been partitioned with 
ethyl acetate, nearly 50% of the radioactivity present remained in the aqueous fraction. 
Again this probably represented unincorporated phenylalanine and phenylalanine which 
had been utilised in the biosynthesis of extracellular proteins or polar metabolites. Only 
8% of the radioactivity was soluble in the ethyl acetate partitions, which contained the 
isoflavonoids. The extract was then redissolved in methanol, with only 0.4% of the 
radioactivity being lost due to the drying processes. The remaining aqueous fraction 
( M l ) was then acidified to pP12 using 3M hydrochloric acid and repartitioned with ethyl 
acetate as described above, resulting in 41.7% of the label remaining in the aqueous 
layer and 4.8% now being soluble in ethyl acetate. After the organic partitions had 
been combined, dried down and redissolved in methanol 3.2% of label was recovered 
in the acid partitioned fraction M6. Aliquots of M5 and M6 were each manually 
injected onto the analytical HPLC column and one minute fractions were collected 
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throughout the 45 minute gradient described in section 2.7.4 and incorporation into 
each fraction was monitored by liquid scintillation counting. The distribution of 
radioactivity between phenolic, ethyl acetate soluble compounds in M5 and M6 is 
illustrated in figures 4.2.3d(i) and (ii) respectively. The media was hydrolysed with 
Img/ml cellulase in citrate phosphate buffer pH 5.2 to confirm that no glucosylated 
medicarpin was present in the media. It was also noted that in the case of M5 only 62% 
of the label applied to the HPLC column was recovered in the fractions collected, the 
remaining radioactivity presumably either sticking to the column or eluting in the 100% 
acetonitrile wash, which was not analysed. When M6 was applied to the column 94% 
of the label was recovered in the fractions collected, possibly due to the absence of non-
polar metabolites which had been removed from the media in the first partition. In both 
extracts medicarpin clearly represented a major labelled metabolite, although 
phenylalanine could also be seen to be incorporated into numerous other fractions. 
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Figure 4.2.3c The distribution of radioactivity during the extraction of 
isofiavonoids from labelled cells. 
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Figure 4.2.3c summarises the extraction procedure used to prepare labelled 
isoflavonoids from the elicited cells. Of the 8.98xl08dpm total radioactivity in the cell 
extract, after acidification and partitioning into ethyl acetate, only 7.2% remained in the 
aqueous fraction (C3) with 54.1% of total radioactivity in the cells being soluble in the 
organic phase (C4). Following concentration far more radioactivity was incorporated 
into the extract C5 prior to HPLC analysis than had been determined in the extracts fro 
the medium, M5 and M6 (27.2% as opposed to 7.6% and 3.2% respectively). Figure 
4.2d(iii) illustrates the distribution of radioactivity in the fractions collected following 
injection of C5 onto the HPLC column. As in M5 and M6 (figure 4.2d(i) and (ii) 
respectively), there was significant incorporation into the polar fractions eluting early 
from the column, but there was also a major peak corresponding to MGM and the 
second largest peak corresponded to medicarpin. In this extract 57% of radioactivity 
applied to the column was recoverable in the 45 fractions collected, the remainder being 
either bound to the column or eluted in the acetonitrile wash. 
Extracts M5 and M6 (total volume lOmls) were injected onto the preparative HPLC 
column in 300)il injections and the peaks corresponding to MGM (21 minutes) and 
medicarpin (31 minutes) collected manually (figure 4.2.3e). The identity of medicarpin 
had been established by coinjecting an authentic sample of medicarpin onto the 
preparative column prior to collecting fractions. C5 (9ml) was also applied to the 
column in 300^il injections, with MGM being collected between 20 and 22 minutes. A 
typical HPLC profile showing the elution of the compounds of interest is shown in 
figure 4.2.3e. The fractions containing medicarpin or MGM were independently 
combined, partitioned twice into ethyl acetate, then dried over anhydrous sodium 
sulphate and rotary evaporated to dryness. The residue was then redissolved in 
methanol and examined by analytical HPLC. The identity of [l^C-medicarpin]-
glucoside-malonate was confirmed by enzymically hydrolysing the conjugate to release 
l^C-medicarpin (figure 4.2.3f). After preparative HPLC, the fractions containing 
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Figure 4.2.3d Incorporation of L-[U-14C]phenylaIanine into phenolic 
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Figure 4.2.3f The conflrmation of the identity of [14c-medicarpin]-3-
0-glucoside-6"-0-malonate by hydrolysis to [14c]-medicarpin (i) 
extract incubated in citrate phosphate buffer pH 5.2 alone (ii) incubated 
in cellulase and buffer overnight. Extracts analysed by H P L C and 
fractions (Imin) assayed for radioactivity. The radioactive peak 
corresponding to medicarpin coeluted with the authentic phytoalexin as 
determined by monitoring the eluent for UV absorbance. 
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Figure 4.2.3g A diagram of a typical T L C plate showing that although 
the medicarpin appeared to be pure when analysed by H P L C it could 
clearly be resolved into two peaks by T L C (chloroform: methanol 98:2). 
bb=bright blue under UV light (k 254), dp=dark purple. Authentic 
medicarpin (M) was dark purple and the unknown compound termed 
pseudomedicarpin (PM) had a bright blue fluorescence. 
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Figure 4.2.3j Mass spectra of pure medicarpin following 
(i) electron impact and (ii) chemical ionisation. Authentic 
medicarpin has an expected relative molecular mass of 270. 
medicarpin were reanalysed by analytical HPLC and liquid scintillation counting. The 
radiochemical purity of the medicarpin collected from the preparative column was only 
40% from MS, 31% from M6 and 12% from C5. In some instances this was probably 
due to the large injection volume which resulted in poor chromatography and 
"smearing" between fractions. When analysed by TLC (chloroform:methanol, 98:2 
v/v) and viewed at 254nm all three samples of partially purified medicarpin contained a 
bright blue band (Rf value 0.50), running slightly above the dark purple medicarpin (Rf 
value 0.45). Both the Rf 0.5 metabolite and medicarpin were further purified by TLC 
and the unknown compound scraped off the TLC plate, dissolved in methanol and 
analysed by UV scanning spectroscopy between the wavelengths 200 and 350nm. It 
was found that this compound had the characteristic pterocarpan UV profile, with 
maximum absorbance at 283nm which is very similar to that of the pure medicarpin, 
(figure 4.2.3h). Interestingly it also had a very similar retention time to medicarpin on 
the analytical HPLC column, and when authentic medicarpin was "spiked" with this 
unknown compound the chromatogram appeared as one peak (figure 4.2.3i). 
Significantly, the fraction containing medicarpin which was collected from the 
preparative column elated as two closely migrating UV absorbing peaks and it seems 
likely that one was medicarpin and the other pseudomedicarpin ( figure 4.2.3e). The 
compound was termed "pseudomedicarpin" and was a particulariy interesting find as its 
occurrence has not been previously reported in alfalfa. Its discovery was also 
important as it was necessary to check for the contamination of medicarpin with 
pseudomedicarpin before undertaking feeding studies. The two compounds were 
separated to purity by double development of the TLC plates and the identity of 
medicarpin confirmed by mass spectrometry (figure 4.2.3j). [14C-ring]-labelled 
medicarpin was finally purified to 98% radiochemical purity as analysed by HPLC and 
with a specific activity of 467 dpm/nmol (8Bq/nmol). 
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4.3 Preparation of [3H-methyI]-labeiled medicarpin from 
I^H-methyll-methionine 
4.3.1 Objective 
The aim of this experiment was to synthesise the side-chain labelled medicarpin of as 
high a specific activity as possible. It was, therefore, carried out on a smaller scale to 
that described in the previous instance. 
4.3.2 Method 
One 60ml flask of 7 day old suspension cultured cells (var. Europe) was treated with 
6.25mg yeast elicitor for 8h in the dark at 25°C. lOmls were then transferred to a 
sterile centrifuge tube and treated with 10)J.g/ml cycloheximide for 30 minutes. 
Cycloheximide was added to prevent methionine incorporation into protein thus 
maximising the labelled methionine input into the isoflavonoid pathway. 1.85MBq 
[3H-methyl]-methionine were added for a further 2h and the cells harvested by 
centrifugation After rinsing the cells in sterile media the cells were recovered by 
recentrifuging prior to freezing in liquid nitrogen and storing at -20^C. Centrifugation 
was used instead of filtration in this instance to minimise label lost through the 
transferral of extracts. The media was collected separately and stored at -20°C. 
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4.3.3 Results 
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Figure 4.3.3a The distribution of radioactivity between cells and media 
following labelling with [3H-methyl]-methionine 
Figure 4.3.3a summarises the distribution of radioactivity between the cell extracts and 
the extracellular medium. Of the 3.63x10^ dpm applied to the cells, 53.7% were 
recovered in the media and 19.7% in the cells. The higher recoveries in this experiment 
are probably due to the changes in method as described above and the short labelling 
time which reduces losses of volatile radioactivity. 
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Figure 4.3.3b The distribution of radioactivity during the extraction of 
isoflavonoids from labelled media. 
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Figure 4.3.3b summarises the recovery of radioactivity during the extraction procedure 
utilised during the processing of the extracellular media (M) of the cell suspension 
cultures treated with [^H-methylJ-methionine. As in the case of cells treated with L-[U-
I'^CJ-phenylalanine, nearly 50% of the radioactivity was found to be present in the 
aqueous phase ( M l ) after partitioning with ethyl acetate. Only 11.2% of the total 
radioactivity present in the media was found in the organic phase (M2), which was 
dried over anhydrous sodium sulphate before rotary evaporation to dryness at 30OC. 
The residue was taken up in methanol (M5), where 6.5% of the original radioactivity 
present in the media was ready for analysis by HPLC. After acidification with 3M 
hydrochloric acid and repartitioning with ethyl acetate, the majority of label remained in 
the aqueous layer M3 (40.2%), with 5.7% being soluble in the organic layer, which 
was then concentrated and redissolved in methanol (M6) with 4.2% of the total counts 
now being suitable for analysis by HPLC. Aliquots of M5 and M6 were each manually 
injected onto the analytical HPLC column and the eluant was collected in one minute 
fractions and incorporation monitored by liquid scintillation counting. The distribution 
of radioactivity in these two extracts is shown in figures 4.3.3d(i) and (ii). The profile 
of incorporation can be seen to differ from that observed with the phenylalanine label, 
with much lower background radiation and more defined peaks of radioactivity. Again, 
medicarpin can clearly be seen to be a labelled metabolite. There can also be seen a 
large peak of radioactivity being collected in the early fractions of eluant collected 
representing either very polar metabolites or perhaps the disintegration of the labelled 
[3H-methyl]-methionine molecule to [^H-methanol]. Two peaks of radioactivity were 
also observed with retention times of 30 and 42 minutes in both extracts M5 and M6, 
which had not been observed in the phenylalanine labelling study. In this study 88% of 
radioactivity applied to the HPLC column was recoverable from extract M5 in the 45 
fractions collected, but only 16% were recovered from the M6 fraction. 
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Figure 4.3.3c The distribution of radioactivity during the extraction of 
cells labelled with [3H-methyl]-methionine. 
The extraction of the [3H-methyl]-methionine treated cells is shown in figure 4.3.3c. 
The distribution of radioactivity during the extraction of the methionine treated cells was 
markedly different to that obtained throughout the preparation of [^^cj.phenylalanine 
treated cells. Only 48% of the total radioactivity present in the acetone and methanol 
extract was recovered in the concentrate C2 and after acidification and repartitioning 
28.3% remained in the aqueous fraction C3, with 12.8% being found in the organic 
layer C4 and 0.2% being lost in the subsequent concentration under vacuum and 
resuspension in methanol (C5). The percentage of radioactivity recovered from the 
fractions collected from the HPLC column was 64%. As illustrated in figure 4.3.3d(iii) 
the profile of radiolabel incorporated was again significantly different to that obtained 
with the [14c]-phenylalanine feeding study. Very little radioactivity was eluted in the 
polar fractions, unlike the radioactivity distribution observed in fractions M5 and M6. 
The major peaks of radioactivity were medicarpin and also the peaks observed in the 
media extracts with retention times of 30 and 42 minutes. 
70 
MS 
3000000 
dpm 
2000000 
1000000 H 
Medicarpin 
l i m . i ^ . ^ . . i M . . ^ l . i ^ . M . . . ^ . . I * a l . i * . - ^ . . . I L 
—c K Tf If 1^  a cr c - (\ K i If M r~ a (T c - ^ K I T y ^ a o c - r-K ir r oc a c r> r< m 
R T 
(i) 
M6 
200000 
dpm J 
100000 J 
(ii) 
0 - K I 
Medicarpin 
-OKflirvor acre—CK^iTvit^acrc-t^K-oiryir-aiTC-c^n^iru race-(SK 'flin 
R T 
(iii) 
C5 
120000 
dpm 
100000 
80000 
60000 H 
40000 
20000 I iIIIIUIIl^IJIIMUI. 
Medicarpin 
IIMUI MX 
R T 
Figure 4.3.3d Incorporation of ["^H-methyl]-methionine into phenolic 
compounds in fractions (i)M5, (ii)M6 and (iii)C5. 
Due to the problems encountered using the preparative HPLC it was decided to purify 
the medicarpin by thin layer chromatography alone. The sheer volume of extract 
resulting from the extraction processes used in the previous study (totalling 19mls for 
M5, M6 and C5) necessitated multiple injections onto the preparative HPLC column, 
which v^ as both lengthy and resulted in poor chromatography. TLC had the advantage 
that several chromatograms could be run concurrently and that the medicarpin could be 
readily identified using previously purified standards and the UV absorbing spot could 
simply be scraped off the TLC plate and the phytoalexin washed off the silica directly 
into methanol. Medicarpin was initially purified from the media extracts M5 and M6 as 
these extracts were cleaner and in total contained more medicarpin than found in the cell 
extract C5. A diagrammatic representation of a TLC separation of the media extract is 
given in figure 43.3c. The UV absorbing spots of interest were also analysed by 
HPLC and UV-spectroscopy to confirm identity and level of purity. 
Figure 4.3.3e illustrates the importance of checking the purity of metabolites by more 
than one analytical method. Three compounds, including medicarpin, can be seen to 
elute from the HPLC column concurrently with retention times of 34 minutes (bands 1, 
6 and 7) and would thus be indistinguishable by HPLC analysis alone. 
Pseudomedicarpin and medicarpin, which run as a single peak on HPLC 
chromatograms can be seen to be separated by thin layer chromatography (bands 6 and 
7 respectively), but the UV-spectroscopy suggested that the compounds were still not 
100% pure as the spectra and wavelengths of maximum absorbance were not identical 
to those found during previous purifications. It was, therefore, necessary to further the 
isolated metabolites by TLC until the medicarpin could be seen to be pure by TLC, 
HPLC and UV-spectroscopy. Radioiabel purity was assessed by collecting fractions 
eluting the analytical HPLC column and liquid scintillation counting. [^H-methyl]-
labelled medicarpin was purified to a radiochemical purity of 98.7% (by HPLC) and 
specific activity of 17Bq/nmol (1020dpm/nmol). 
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Figure 4.3.3e Diagram of a typical T L C plate of a bulk extract of 
elicited media. Compounds were identifled by the UV absorbance and 
in some instances characteristic colours or fluorescence when viewed at 
254nm. Metabolites were then scraped oH' the plate and their retention 
time determined by H P L C and their absorption spectra determined by 
UV spectroscopy. 
4.4 Preparation of [3H-ring]-Iabelled medicarpin from [ 3 H ] -
phenylalanine 
4.4.1 Objective 
The aim of this final preparation of radiolabelled medicarpin was to synthesise enough 
ring labelled phytoalexin of high specific activity to carry out an extended feeding study 
in elicited and unelicited alfalfa cell cultures and also in seedlings. 
4.4.2 Method 
[^H-ring]-labelled medicarpin was synthesised using [^HJ-phenylalanine as a precursor 
in elicited cells. [^Hj-phenylalanine can be purchased at a far higher specific activity 
than [14c]-phenylalanine (3.7-4.8TBq/mmol and 16.6GBq/mmol respectively) so it 
was hoped to produce labelled medicarpin with higher specific activity than that 
observed in the previous study. 10x60ml flasks of 7 day old suspension cells (var. 
Europe) were each treated with 6.25mg yeast and 3.7MBq ^H-phenylalanine 
(3.7TBq/mmol) for 9h in the dark at 250C. Cells were harvested by vacuum filtration 
and washed with 50ml H2O before freezing in liquid nitrogen and storing at -20OC. 
The medium was combined with the 50ml wash and the fractions analysed by 
scintillation counting as they were partitioned. Cells were extracted in acetone and 
methanol as described previously. 
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4.4.3 Results 
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Figure 4.4.3a The distribution of radioactivity between media and cells 
following labelling with [3H]-phenylalanine 
As observed in the study with [^^Qj.piignyiai-j^ine, significantly more label was lost 
than observed in the [3H]-methionine labelling study, with only 12.2% of the total dose 
fed to the cells being recovered in the cell extract and 13.2% in the media. As 
compared with the [^Hj-methionine labelling study the experiment was carried out on a 
much larger scale with ten 60ml flasks of cells being treated as opposed to lOmls in the 
preparation of [^H-methylj-medicarpin. The processing of such large volumes of 
material would inevitably result in the loss of some label, but another important 
difference between the phenylalanine studies and the methionine study are that 
phenylalanine is a substrate for many cell wall bound phenolics which become 
incorporated during the elicitation response and this probably accounts for the major 
loss in extractable radioactivity. 
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Figure 4.4.3b The distribution of radioactivity during the extraction of 
media from cultures labelled with [3H]-phenylalanine 
Less emphasis was made on the study of incorporation of [^HJ-phenylalanine during 
this study as it had already been carried out previously with the [^^c].phenylalanine. 
Therefore, the media was simply extracted twice with ethyl acetate which was dried and 
concentrated as described earlier. Again, the majority of recovered counts were to be 
found in the aqueous layer of the partition, probably representing unincorporated 
phenylalanine. Although the distribution of radioactivity between phases was in a 
similar ratio to that observed following labelling with [^'^C]-phenyIalanine, actual 
recoveries were significantly higher with [^HJ-phenylalanine, presumably due to 
improved practical techniques. An aliquot of the concentrated organic phase from the 
media (M3) was injected onto the HPLC. 98% of the radioactivity applied to the 
column was recoverable in the fractions collected. As can be seen from figure 4.4.3d(i) 
the major peak of radioactivity in the organic phase from the media eluted with 
medicarpin and medicarpin was subsequently purified from the M3 by TLC 
(chloroformrmethanol 98:2 v/v) as described for [3H-methyl]-labelled medicarpin. 
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Figure 4.4.3c The distribution of radioactivity during the extraction of 
cells labelled with [^HJ-phenylalanine. 
The cells were extracted exactly as described previously and similar final recoveries 
were observed to those found in section 4.2. The aqueous fraction C3 contained 
19.0% of the total extractable radioactivity while the final concentrated extract of the 
organic phase (C5) contained 23.5%. An aliquot of the final extract C5 was injected 
and as determined with the medium medicarpin was a major radioactive metabolite. In 
addition MGM was also a major [^Hj-labelled product (figure 4.4.3d(ii)). 
It was again decided to used the media extract as a suitable source to purify medicarpin 
in the first instance as the phytoalexin was present in this extract as the major 
phenylalanine derived metabolite and the sample would be cleaner for purification use. 
Medicarpin was purified from M3 by TLC as described for [^H-methyl]-medicarpin 
and the radiolabelled purity of [^H-ringj-medicarpin was finally calculated to be 98% as 
determined by HPLC, with a specific activity of 533 dpm/nmol (9Bq/nmol). 
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Figure 4.4.3d Incorporation of [-^HJ-phenylalanine into phenolic 
compounds in fractions (i)M3 and (ii) C5. 
CHAPTER 5 
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The uptake and metabolism of radiolabelled 
medicarpin in alfalfa cell cultures 
5.1 Introduction 
Overall Objectives 
Although the synthesis of medicarpin has been studied in detail in alfalfa (see section 
1.3) little is known regarding its further metabolism. One route of metabolism is 3-0-
glucosylation followed by 6"-0-malonylation of the glucose moiety [73]. Dewick also 
proposed that the isoflavan vestitol could be formed from medicarpin in a reversible 
manner [33]. However it is clear that these routes of metaboHsm can only account for a 
small proportion of the disappearance of medicarpin which occurs in elicited cell 
cultures. In this part of the programme the rates and routes of medicarpin metabolism 
have been determined in alfalfa. Cell suspension cultures (var. Vela) and seedlings 
(var. Europe) were incubated with radiolabelled medicarpin to follow route(s) of 
metabolism and where possible the metabolites were isolated and identified. Elicited 
and unelicited cell cultures were used to establish whether the further metabolism of 
medicarpin was induced, repressed or unaltered during elicitation. 
5.2 Incubation of [I'^C-ringJ-labelled medicarpin in cell 
suspension culture 
5.2.1 Objectives 
(1) To monitor the metabolism of medicarpin by HPLC analysis; (2) to determine 
whether the metabolism was affected by elicitor treatment; (3) to detemiine whether the 
metabolism occurred within the cells or in the extracellular media. 
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5.2.2 IVIethod 
60ml of 7day old alfalfa cell cultures (var. Vela) were either left untreated (control) or 
treated with yeast elicitor for 8h and then harvested by centrifugation for 5 min on a 
bench top centrifuge. After removal of the media, the cells were resuspended in fresh, 
sterile media. The cells were then resuspended in 60ml of fresh medium and incubated 
with 6.5nmol 8Bq/nmol (467dpm/nmol) [^^C-ring]-labelled medicarpin. At timed 
intervals (10, 30, 60 and 120min) duplicate incubations were harvested by 
centrifugation and the cells and medium analysed separately for radioactive metabolites 
as described in section 2.9. The conditioned media which had been removed 
previously from the elicited and unelicited cells was also incubated with labelled 
medicarpin to test for extracellular metabolism. The recovery of medicarpin from sterile 
media was also monitored to determine the amount o f radioactivity lost during 
extraction and analysis. Analyses of samples were carried out as described previously. 
was collected overnight from a flask of cells that had been treated with [^ "^C-
ring]-labelled medicarpin to monitor the breakdown of medicarpin to C02 and from a 
control flask which was untreated to monitor background levels of ^^C02. Air was 
circulated over the flasks using a vacuum pump to prevent a build up of ethanolamine 
which was used to trap the carbon dioxide. 
5.2.3 Results 
Uptake of radioactivity 
Figure 5.2.3a illustrates that medicarpin was rapidly taken up by the cells and also that 
the initial uptake was significantly faster in the elicited cells than in the unelicited. The 
elevated rate of uptake in the elicited cells suggested that either; (1) medicarpin was 
taken up faster in the elicited cells because it was being metabolised faster, or (2) it was 
being taken up by an active, or elicitor-activated transport process. 
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Figure 5.2.3.a The uptake of radiolabelled medicarpin in equivalent 
amounts of elicited and unelicited cells following addition of [I '^C-ring 
labelled]-medicarpin to the media. Error bars represent the standard 
deviations of triplicate determinations. 
The distribution of the administered radioactivity was studied in detail in the various 
fractions. Approximately 15% of the dose could not be partitioned into ethyl acetate 
from the medium suggesting that some of the [l^C]-medicarpin had degraded to highly 
polar metabolites. To monitor for mineralisation the ^^C02 evolved form the cells 
during a 16h incubation with l^c.^edicarpin was determined after capturing the 
14C02 in a gas jar containing ethanolamine. Over 16h only 10% of the dose could be 
recovered as^^C02. The cell wall fractions were incubated in tissue solubiliser for 2h 
and then subject to liquid scintillation counting. Negligible radioactivity was associated 
with the insoluble fraction in any of the treatments. 
H P L C analysis of medicarpin metabolism 
Figures 5.2.3b-e illustrate the radioactivity detected in the media and cell extracts as 
collected from the HPLC column after various periods of incubation (0-120 minute). 
Metabolism was only monitored up to two hours after incubation with the labelled 
medicarpin following the preliminary studies described in Chapter 3 with unlabelled 
coumestrol and formononetin suggested that the isoflavonoids had disappeared from 
the media within 10 minutes of addition. In this study, after 10 minutes of the 
incubation with ^^C-medicarpin, the major peak of radioactivity still corresponded to 
the unchanged phytoalexin (figure 5.2.3b) but small peaks of radioactivity could be 
seen beginning to accumulate. These metabolites were termed medicarpin products 
(MPs) and eluted at 17 minutes (MPl), 23 minutes (MP3) and 42 minutes (MP7). The 
numbering of the MPs was based on their relative retention times by HPLC. The 
metabolites accumulating were similar in elicited and unelicited cells and in ehcited and 
unelicited media. After 30 minutes (figure 5.2.3c) a higher proportion of radioactivity 
was observed in the cells than in the media and increased amounts of radioactivity could 
be observed in M P l , MP2 and MP7 with the additional peaks MP2, MP4, MP5 and 
MP6 also becoming visible. Several of these metabolites eluted around 34 minutes (the 
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Figure 5.2.3b The distribution of radioactivity between medicarpin and 
its metabolites as separated by H P L C after a 10 minute incubation of 
[l^C].medicarpin with (i) elicitor-treated cells and (ii) untreated cells. 
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Figure 5.2.3c The distribution of radioactivity between medicarpin and 
its metabolites as separated by H P L C after a 30 minute incubation of 
[l^C]-medicarpin with (i) elicitor-treated cells and (ii) untreated cells. 
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Figure 5.2.3d The distribution of radioactivity between medicarpin and 
its metabolites as separated by H P L C after a 60 minute incubation of 
[l'*C]-medicarpin with (i) elicitor-treated cells and (ii) untreated cells. 
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Figure 5.2.3e The distribution of radioactivity between medicarpin and 
its metabolites as separated by H P L C after 120 minutes in (i) elicited 
cells and (ii) unelicited cells. 
retention time of medicarpin) indicating that they were highly hydrophobic and perhaps 
metabolites closely related to the phytoalexin. Following a 30 minute incubation, the 
proportion of the radioactivity eluting in undefined multiple fractions was higher than 
observed after 10 minutes, perhaps indicating alternative multiple routes of minor 
metabolism. After 60 minutes of incubation radioactivity was still being taken up by 
the cells and incorporation was increasing in the peaks eluting with similar retention 
times to medicarpin. The final analysis carried out at 120 minutes again showed little 
difference between the profile of metabolism in elicited and unelicited cells. When 
labelled medicarpin was incubated in conditioned media from either elicited or unelicited 
cells there was no evidence for metabolism over a 120 minute period and levels of 
recovered medicarpin were very similar to that achieved after incubation with sterile 
media (2603, 2893 and 2991 dpm respectively, dose=3035dpm). 
5.2.4 Conclusions from [14c]-medicarpin feeding study. 
In relation to the objectives described in section 5.2.1 the following conclusions were 
drawn from this study:- (1) HPLG analysis of cells incubated with ^'^C-labelled 
medicarpin for up to 2h demonstrated both the uptake of medicarpin from the media 
into the cells and the formation of multiple metabolites. A consistent pattern of 
metabolism emerged in all samples analysed and the commonly occurring products of 
medicarpin were named MP1-MP7 in order of compounds elution from the HPLC 
column. (2) Metabolism did not appear to be qualitatively affected by elicitor treatment. 
However, the elicited cells took up the phytoalexin more rapidly than the control 
cultures; (3) metabolism did not occur in the exti-acellular media. Interestingly, over the 
course of the 2h incubation there was little evidence for glucosylation of the medicarpin 
fed to the cells. MGM would be expected to be a major metabolite of medicarpin 
according both to the literature discussed in Chapter 1 and also as demonstrated by the 
feeding of radiolabelled precursors of medicarpin to elicited cells described in Chapter 
4. It is interesting to speculate that the medicarpin applied extracellularly to the cells 
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may be incorporated into separate intracellular pools to that synthesised within the cells 
themselves. 
5.3 Incubation of [3H-methyl]-labelled medicarpin in cell 
suspension culture 
5.3.1 Objectives 
(1) The [^H-methylj-labelled medicarpin was incubated in elicited and unelicited cells 
to see i f any patterns of metabolism not detectable with the [l^C-ring]-labelled 
medicarpin could be identified. (2) In contrast to the previous experiment, the 
duplicate incubations were hydrolysed to accurately assess the level of glucosylation of 
exogenously applied medicarpin. (3) To investigate the metabolism of medicarpin 
more thoroughly by analysing both by HPLC and TLC. 
5.3.2 Method 
[^H-methylJ-medicarpin (30nmol, 1020dpm/nmol, 17Bq/nmol) was added to 2ml 
suspension cultures taken from 7 day old Vela cells treated with or without yeast elicitor 
for 8h. In this experiment cells were not washed in fresh media prior to incubation. 
Cultures were incubated with the radiolabelled phytoalexin for 2h and then the media 
and cells were processed as detailed in sections 2.7.1 and 2.7.2. 
5.3.3 Results 
H P L C analysis 
As determined by HPLC the metabolism in [3H-methyl]-labelled medicarpin is 
illustrated in figures 5.3.3(a) and (b). In this study several metabolites of medicarpin 
can clearly be seen. The major radioactive fraction eluted from the HPLC column early 
in the gradient indicating that it was highly polar. Hydrolysis studies suggested that 
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this was not due to the conjugation of radiolabelled metabolites with glycosides as no 
radioactive aglycones could be released. Another possibility which was examined was 
the potential for the transfer of the radioactivity from [^H-methylj-medicarpin to water 
via the process of tritium exchange. This was also discounted as unlikely as this polar 
radioactivity was not observed when cells were incubated with [^H-ring]-labeIled 
medicarpin. It was concluded that the polar metabolite was probably [^H-methanol] 
resulting from the demethylation of [3H-methyl]-labelled medicarpin. Confirmation of 
this has recently been reported by subsequent studies in our laboratory showing the 
volatile nature of this fraction and confirmation of its identity as ^H-methanol by 
derivatisation with benzoyl chloride (Edwards, unpublished observation). The 
metabolites of medicarpin are labelled MPl-7 (Medicarpin Product 1-7) in order of 
elution time in figures 5.3.3a and 5.3.3b and were similar to those determined with the 
[l^C-ringj-labelled medicarpin, with the exception of MP3. Again, MGM did not 
feature as a major metabolite in the cell extracts. In this labelling study similar evidence 
for metabolism was obtained to that described for [I'^C-ringj-labelled medicarpin, 
suggesting that many of the MPs contained much of the original composition of the 
pterocarpan/ isoflavonoid structure. However, with the['^H-methyl]-medicarpin 
feeding study incorporation into the products appeared to be more pronounced. 
Hydrolysis and T L C analysis 
Extracts from cells and media incubated for various times with [^H-methyl]-medicarpin 
were hydrolysed overnight and analysed by TLC as described in section 2.7.5. The 
UV-absorbing and fluorescent metabolites were then scraped off the TLC plate and 
eluted in methanol prior to UV-spectroscopy and liquid scintillation counting. The 
identity of radiolabelled metabolites as the corresponding medicarpin products was 
confirmed by injecting the compounds onto the HPLC. I f the compound eluted with 
the expected retention time of the corresponding medicarpin product it was concluded 
that they were the same metabolite. 
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The distribution of radioactivity was very similar in both media from elicited and 
unelicited cell cultures, with the exception of incorporation into MP5, where 638dpm 
were recovered in MP5 from elicited media and only 97 in unelicited. A considerable 
proportion of the radioactivity was still retained as medicarpin (average 533dpm) in 
agreement with the HPLC analysis. However, the TLC analysis also demonstrated that 
a considerable amount of radioactivity (176dpm in control media and 289dpm in elicited 
media) was incorporated into pseudomedicarpin thus suggesting that 
"pseudomedicarpin" was a metabolite of medicarpin. 
In the cell extracts, the distribution of radioactivity between treatments was similar, 
with the major exception that in this instance, incorporation of radioactivity into MPS 
was far higher in the control cells than in the elicited cell extracts (1092dpm and 
187dpm respectively). This was in contrast to the distribution found in the media and 
suggested that although the pattern of metabolism was the same in both treatments, the 
distribution of MP5 between the media and the cells was altered by elicitor treatment. 
5.3.4 Conclusions from [3H-methyI]-inedicarpin feeding 
study 
Similar profiles of medicarpin products were seen to those observed with the ^Re-
labelled medicarpin, with the major exception of the polar methanol (P) product. The 
specific activities of the products appeared to be much higher than obseived previously. 
For example figure 5.3.3a illustrates that in the unelicited cell extract incorporation of 
radioactivity is actually higher in MP7 than that remaining in the peak M representing 
medicarpin and pseudomedicarpin. This aspect of the data is confusing, in that since it 
appeared that the [^H-methylJ-labelled medicarpin was metabolised to the same 
products as the ^^C-labelled medicarpin, the relative proportion of the phytoalexin 
metabolised to these products would have been expected to be the same in both studies. 
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This difference could be due to natural variation often observed when using different 
batches of cell cultures but was more likely to be due to the difference in dosage of 
medicarpin. Thus, while 30nmol of [^H-methyl]-medicarpin was applied to a 2nil 
culture of cells, 6.5nmol of [l^C-ringj-labelled medicarpin was administered in the 
previous study. The difference in levels of metabolism may also have been due to other 
changes in methodology as the cells were not centrifuged and resuspended in fresh 
media prior to medicarpin incubation in the study with [^H-methylj-medicarpin. 
Resuspension of cells in fresh medium in the studies with [l^C-ring]-labelled 
medicarpin may have inhibited cellular metabolism and resulted in reduced rates of 
phytoalexin degradation in the earlier studies. 
One important observation in this experiment was the absence of a peak of radioactivity 
at 24 minutes representing MP3. This was present in the [l^C-ringJ-labelled-
medicarpin feeding experiment and as will be shown in section 5.4 was one of the 
major metabolites of medicarpin formed in the longer incubation with [^H-ring]-
labelled medicarpin. This compound probably represents a demethylated product, 
although further experiments would be needed to confirm this observation. 
Unfortunately, there was very little UV absorbance associated with this peak and it 
proved impossible to isolate and charaterise in detail. 
5.4 Incubation of [^H-ringJ-labelled medicarpin in cell 
suspension cultures 
5.4.1 Objectives 
The aims of this incubation were to study the metabolism of medicarpin over prolonged 
incubation periods. In order to do this it was decided (1) to continue the labelling for a 
longer period of time, to follow the metabolism further than initial metabolites; (2) to 
study metabolism primarily by TLC, with extracts of interest being additionally 
analysed by HPLC. (3) To extend the gradient during HPLC by changing solvent B 
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ratios from 20-60% to 20-100% to ensure a thorough investigation into metabolism to 
more hydrophobic products was achieved. A further aim of this study was to verify 
whether pseudomedicarpin was indeed a metabolite of medicarpin as indicated in the 
previous incubation. 
5.4.2 Method 
179nmol of [^H-ringJ-labelled medicarpin (533dpm/nmol 9Bq/nmol) was fed to 2ml 
suspensions of elicited and unelicited cells, elicited and unelicited conditioned media 
(prepared as detailed in section 5.3) and also to cell cultures which had been heat killed 
by boiling. Cells were harvested in duplicate Ih, 2h, 4h, 8h and 12h after addition of 
[^H-ringl-labelled medicarpin. 
5.4.3 Results 
H P L C analysis 
The data resulting from the extended HPLC gradient used is not shown as no 
radioactivity was recovered in fractions eluting after the normal gradient in extracts 
from the cells or media of cells treated with [^H-ringj-labelled medicarpin. This result 
confirmed that medicarpin was not being metabolised to metabolites of increased 
hydrophobicity. The radioactivity associated with extracts from elicited and unelicited 
cells following exposure to [^HJ-medicarpin is illustrated in figure 5.4.3a. As in the 
previous study, uptake of medicarpin was more rapid in elicited as compared with 
unelicited cells. The results demonstrated that levels of radioactivity were maximal at 
4h in elicited cells and this was the first extract to be analysed by HPLC. In the cells, 
contrary to previous studies there was litde evidence of metabolism during a 4h 
incubation with [^HJ-medicarpin in either elicited or unelicited cells, with the exception 
of a very minor peak cochromatographing with MGM, which was observed only in the 
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Figure 5.4.3a The uptake of radiolabelled medicarpin in equivalent 
amounts of elicited and unelicited cells following addition of [^H-ring]-
labelled medicarpin to the media. Error bars represent the standard 
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Figure 5.4.3b The distribution of radioactivity between medicarpin and 
its metabolites as analysed by H P L C in the media of (i) unelicited and 
(ii) elicited cells after 4h incubation with [ • ' H - r i n g ] - l a b e l l e d 
phytoalexin. 
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Figure 5.4.3c The distribution of radioactivity between medicarpin and 
its metabolites in media of (i) elicited cells and (ii) unelicited cells after 
8h incubation with [^H-ringJ-labelled phytoalexin. 
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Figure 5.4.3d The distribution of radioactivity between medicarpin and 
its metabolites in media of (i) elicited cells and (ii) unelicited cells after 
12h incubation with [^H-ringJ-labelled phytoalexin. 
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Figure 5.4.3e The % of the radioactivity applied to a T L C plate as 
medicarpin and pseudomedicarpin in extracts from (i) elicitor treated 
cells and (ii) untreated cells. 
elicited extract (data not shown). However, in the media metabolites were observed 
between 0-4h. After one hour, the only metabolite of [^Hj-medicarpin that could be 
observed was MP2, which could still be observed after two hours (data not shown). 
However, as compared with the radioactivity associated with medicarpin (including 
pseudomedicarpin) MP2 was a very minor radioactive component of the media extract. 
MPS could also be seen in the media extract of unelicited cells at 2h. By 4h metabolites 
of MPl, MP2 and MP3 could be determined in extracts from elicited media (figure 
5.4.3b). In the unelicited media only MP3 was observed. As the incubation time 
increased MP3 became a more dominant metabolite (figure 5.4.3c), though by 12h a 
significant amount of MP5 had accumulated. At the latter time points the profile of 
radioactive metabolism appeared to be similar in both the control and elicited media. 
Metabolism of medicarpin to pseudomedicarpin as determined 
by T L C 
Analysis by scintillation counting of medicarpin and pseudomedicarpin resolved by 
TLC clearly demonstrated the conversion of at least some of the medicarpin to 
pseudomedicarpin over the time course of 12h (figure 5.4.3e). There was no 
significant difference between the rate of metabolism between elicited and unelicited 
cells. The amount of total radiolabelled medicarpin declined sharply after Ih at which 
point incorporation into pseudomedicarpin was already visible. After 12h the 
proportion of radioactivity in each of the two compounds was approximately equal at 
around 15% of the radioactivity applied to the TLC plate. 
Conclusions from [3H-ring]-labelled medicarpin 
This study confirmed the incorporation of radioactivity from medicarpin into the same 
metabolites observed in the previous two incubations. However, the extended time 
course investigated allowed some speculation as to the order in which the metabolites 
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were formed. For example, N4P2 was the first metabolite to be clearly observed after 
Ih and MPS was similarly observed early on in the unelicited cells after 2h. After 4h 
MPS emerged as the dominant metabolite, together with MPl which was also 
accumulating in the elicited cells. After 8h levels of MPl and MP3 were still increasing 
in both treatments as was MPS and in the elicited extract MP7 was also seen to 
accumulate. The HPLC analysis suggests that MP2 and MPS are primary metabolites 
of medicarpin, while MPS and MP7 accumulate as later metabolic products. The final 
extraction at 12h again demonstrated the presence of MPl-S. Even though the 
formation of medicarpin products can be shown to be time dependent and individual 
metabolites can be shown to accumulate at different times, this study does not show 
that the metabolites accumulating later are derived from those which accumulate earlier. 
In order to ascertain whether these products represent several different pathways of 
medicarpin metabolism or one route of detoxification, it would be necessary to 
individually purify the radiolabelled products, and incubate them in alfalfa cell cultures 
to demonstrate interconversion. The fact that labelled medicarpin was still present in 
elicited and unelicited cell and media extracts 12h after addition to the cell cultures was 
surprising in view of the previously detemiined rapid metabolism of the phytoalexin. 
The longevity of medicarpin probably resulted from the high levels of the phytoalexin 
applied (179nmol/ml culture). However, similar levels of medicarpin were commonly 
observed in elicitor-treated cell cultures and the cultures were able to rapidly degrade the 
endogenous compound. 
An important finding of this experiment was to clearly establish that 
"pseudomedicarpin" was a major metabolite of medicarpin in both elicited and 
unelicited cells. Any differences observed in metabolism of medicarpin by elicited and 
unelicited cells in this experiment were fairly minor, and not any greater than might be 
expected than the natural variation observed when cell cultures are used in metabolism 
studies. 
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5.5 Characterisation of metabolites 
In order to characterise medicarpin metabolites it was necessary to purify them from 
medium of unlabelied elicitor-treated ceils. To confirm that the isolated products were 
MPs, the isolated compounds were cochromatographed with the radioactive MPs by 
TLC and HPLC. 
5.5.1 Characterisation of M P l 
MPl was successfully purified by preparative HPLC of extracts from unlabelied, 
elicited media by replacing solvent A (10% phosphoric acid) with milliQ water (figure 
5.5.1a). When analysed by TLC (chloroform:methanol 95:5) its Rf value was 0.06 
(see figure 5.3.3c). MPl showed a lilac colour fluorescence when viewed under UV 
light (254nm). The pure MPl eluted as a single peak on HPLC (figure 5.5.1b and had 
an absorption maximum at 328nm (figure 5.5.1c). As determined by chemical 
ionisation mass spectroscopy its relative molecular mass was 166 (figure 5.5.1d). 
Further characterisation was not attempted. 
5.5.2 Characterisation of MP2 and MP3 
MP2 and MP3 proved difficult to purify, especially using HPLC. Using TLC, MP2 
was purified to a single compound and had an absorption maximum of 256nm as 
determined by UV spectroscopy (figure 5.5.2). HPLC analysis showed that this 
compound was unstable and further characterisation was unsuccessful. Similarly it 
was not possible to purify adequate quantities of MP3 for UV or mass spectrometry. 
However, the metabolism work described eariier in this chapter does indicate that MP3 
is a demethylated metabolite of medicarpin. 
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single band frcm TLC plate (chloroform:methanol 95:5). 
5.5.3 Characterisation of MP4 
MP4 was identified as the isoflavan vestitol, by comparison with authentic samples 
(kindly provided by Dr. M.P. Robbins, Plant Cell Manipulation Group, IGER, 
Aberystwyth). MP4 cochromatographed with vestitol both by HPLC and TLC and its 
UV spectrum was similar to published spectra (figure 5.5.4). 
5.5.4 Characterisation of MPS and MP6 
MP5 was purified by a combination of HPLC and TLC. The UV absorbance spectrum 
was found to be similar to the published spectra of 4-methoxymedicarpin, variabilin 
and 2-methoxymedicarpin (all of which are pterocarpans) [65] (figure 5.5.4a). 
Analysis by mass spectrometry revealed a relative molecular mass of 300 (figure 
5.5.4b) and the fragmentation pattern was similar to the published data for variabilin 
[12]. MP6 only appeared transiently, and never accumulated in sufficient quantities to 
attempt purification. 
5.5.5 Characterisation of MP7 
MP7 was identified as the isoflavan sativan by reference to authentic standards (again 
provided by Dr. M.P. Robbins) by a combination of HPLC, TLC and UV-spectral 
analytical techniques. The structure and UV spectrum of sativan is shown in figure 
5.5.5. 
5.5.6 Characterisation of "pseudomedicarpin" 
Difficulties were encountered sepiu-ating enough "pseudo-medicaipin" from medicarpin 
to send off for analysis by mass-spectroscopy using preparative TLC alone as the two 
compounds overlapped when applied to the plate in large quantities. Even when 
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normal phase HPLC was employed (data not shown), with a variety of different 
solvent systems, separation was still not satisfactory, so "pseudomedicarpin" was 
finally purified by multiple runs on analytical TLC using chloroformrmethanol 95:5 as 
the developing solvent. As described in Chapter 4 the UV spectrum of 
"pseudomedicarpin" is very similar to that of medicarpin as is the characteristic 
pterocarpan UV absorption spectrum. However, on TLC plates the two compounds 
fluoresced quite differently when viewed under UV light. Medicarpin appeared dull 
purple while pseudomedicarpin was a fluorescent blue. As the characteristics of the 
two compounds were so similar, both compounds were methylated with diazomethane 
to ascertain whether or not they were structural isomers. The incubation was left to run 
at room temperature overnight to facilitate methylation of all available hydroxy groups. 
The methylated products were spotted onto a TLC plate and developed in 100% 
chloroform. UV absorbing spots were then scraped off and analysed by UV scanning 
spectroscopy. A diagram of the developed TLC plate is shown in figure 5.5.6a. UV 
absorbing compounds running as the upper two rows of spots (1,7,9,13,17,2,8,14 
and 18 on figure 5.5.6a) and the row of spots remaining on the origin (6,12,16 and 19) 
running in the lanes of all the methylated compounds were caused by contaminants in 
the diazomethane. After ignoring these UV-absorbing artefacts, the lanes containing 
methylated pseudomedicarpin and a mixture of pseudomedicarpin and medicarpin both 
showed the presence of three reaction products (3,4,5 and 9,10,11 respectively) while 
only one compound (15) was observed in the lane containing methylated medicarpin 
alone. The presence of multiple methylated reaction products with pseudomedicarpin 
was unexpected. The co-migration of metabolite (3) with methylated medicarpin, (15) 
initially suggested that the pseudomedicarpin preparation could contain a structural 
isomer of medicarpin, which has been found in a number of legumes [65]. However, 
i f this was the case then the metabolite (3) should have given an identical fluorescence 
to methyl-medicarpin (15). However, this was not the case. The presence of more 
polar methylated products suggests that either the pseudomedicarpin preparation is 
contaminated with other compounds or degradation products, or that it contains 
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pseudomfidicarpin following chemical ionisation. 
additional hydroxy groups of differing susceptibility to methylation. A similar 
methylation experiment was also carried out using the 6a-hydroxymedicarpin metabolite 
variabilin (MPS) instead of medicarpin. The results from this experiment again 
demonstrated that pseudomedicarpin was not a structural or optical isomer of variabilin. 
To further characterise pseudomedicarpin the purified compound was analysed by 
chemical ionisation mass spectroscopy which gave a clear mass ion of 287 i.e. a 
relative molecular weight of 286. The spectrum produced (figure 5.5.6b) also showed 
the contaminating presence of medicarpin although this had not been visible by any 
other method of analysis. This indicated that pseudomedicarpin was probably a 
hydroxylated derivative of medicarpin, but the mass spectrum did not give any 
indications as to where the extra hydroxyl group was positioned. There was no 
evidence of fragments arising from dehydration which would normally be indicative of 
a 6a or 5a hydroxypterocarpan [65]. It is possible to chemically dehydrate 6a-
hydroxypterocarpans to the corresponding pterocarpene with the addition of 
concentrated hydrochloric acid [65] and observing the appearance of two diagnostic 
maxima in the 335-360nm region. However, no such spectral shift was observed 
when pseudomedicarpin was incubated with concentrated hydrochloric acid so it seems 
likely that the position of the additional hydroxy group is not at the 6a position. This, 
and the kinetics of appearance of pseudomedicarpin would suggest that 
pseudomedicarpin is not the intermediate between medicarpin and variabilin, but 
represents a separate route of medicarpin metabolism. 
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5.6 Incubation of pseudomedicarpin in cell suspension 
culture 
5.6.1 Objective 
Radiolabelled pseudomedicarpin prepared from elicited cells incubated with [^H]-
phenylalanine incubated cells was fed to elicited and unelicited cells in order to see i f its 
metabolism could be followed further and hence determine whether or not it was an 
intermediate in medicarpin degradation. 
5.6.2 Method 
43nmol (1006dpm/nmol, 16.7Bq/nmol) [^H-ringJ-labelled pseudomedicarpin was 
incubated in 2ml of elicited and unelicited cell cultures for 2h as described in section 
5.3. Due to the limited radioactivity available the cells were homogenised with the 
media in acetone as described in Chapter 2. The metabolites were then identified and 
analysed by TLC, scintillation counting and UV-spectroscopy. 
5.6.3 Results 
The distribution of radioactivity between pseudomedicarpin and its metabolites was as 
illustrated in figure 5.6.3. As can be clearly seen, very few counts could be seen 
remaining in the pseudomedicarpin after 2h, suggesting it was being degraded very 
quickly. The major radioactive metabolite was the brightly fluorescent purple band 
corresponding to MP2 which run just beneath medicarpin. Radioactivity was also 
associated with the dark purple band corresponding to medicarpin, which could indicate 
conversion back to medicarpin but the possibility of poor resolution between 
medicarpin and MP2 cannot be ruled out. 
92 
Compound 
Identity 
CE) dp 
dp 
Gi) bp 
(3) bp 
@> dp 
<®> bp 
(2) y 
ci:) (g) © dp 
dp 
p 
(£) ( 3 4 ) ( 4 5 ^ dp 
dp 
d o ) fl 
( 3 7 ) CiD dp 
p 
E E Co Co 
PM 
M 
MP2 
Origin 
Figure 5.6.3 The recovery of radioactivity from a T L C plate as 
pseudomedicarpin and metabolite MP2 in extracts from alfalfa cell 
cultures incubated with [^H-ring]-labelled pseudomedicarpin for 2h. 
Circled numbers represent dpm recovered. E=elicited, Co=control. 
Colour abbreviation dp=dark purple, bp = bright purple, p=purple, fb= 
f l u o r e s c e n t b lue , f l = f l u o r e s c e n t l i l a c , y = ye l low. 
PM=pseudomedicarpin, M=medicarpin. 
CHAPTER 6 
9 3 
The Uptake and metabolism of radiolabelled 
medicarpin in alfalfa seedlings 
6.1 Overall Objectives 
The metabolism of medicarpin in alfalfa had largely concentrated on the use of cell 
cultures and it was also of interest to determine how the phytoalexin was metabolised in 
the seedlings, which have been reported to be able to take up and detoxify medicarpin 
[ 3 7 ] . In addition, studies had concentrated on the metabolism of exogenously applied 
medicarpin and it was of great interest to determine whether this was similar to the 
detoxification of the endogenously produced phytoalexin. To address this latter point 
attempts were made to radioactively label the endogenous medicarpin pool and then 
monitor its turnover using pulse-chase methods and the use of inhibitors which 
selectively block phenylpropanoid, and hence, isoflavonoid synthesis. 
6.2 Feeding of ^H-ring labelled medicarpin to seedlings 
6.2.1 Objectives 
This experiment was designed to ascertain whether or not metabolism of radiolabelled 
medicarpin in seedlings was the same as in cell cultures. The experiment was carried 
out using hydroponically grown seedlings by feeding the radiolabelled medicarpin via 
the roots. The distribution of radioactivity between roots, leaves and the seedling 
growth solution was determined and the nature of the metabolites investigated by 
HPLC and TLC. 
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6.2.2 Method 
75nmol/ml (310dpm/nmol, 5Bq/nmol) [^H-ringJ-labelled medicarpin was dissolved in 
9ml of water and the dose solution divided into 9x1 ml lots in disposable plastic tubes. 
5 twelve day old seedlings were then placed in each pot and incubated for 12, 24 and 
48h. The seedlings were then harvested in triplicate, separated into roots and shoots 
and then frozen at -80OC prior to analysis as described in Chapter 2. 
6.2.3 Results 
Distribution of radioactivity between roots, leaves and 
growth solution 
Table 6.2.3 illustrates the uptake of radioactivity into roots and leaf extracts over the 
48h time course. Radioactivity was significantly higher in the roots than in the leaf 
extracts and the growth solution at all time points. Incorporation into the leaves 
remained constant at just over lOOOdpm (4.3% of the administered dose), whereas in 
the roots incorporation was highest at 12h (8510dpm, 36.6% of the administered dose) 
declining steadily over the time course to 5030dpm (21.6% of the administered dose) at 
72h. As the radioactivity extracted in the leaves was minimal and constant these 
extracts were put aside and analysis was concentrated on the root extracts and growth 
solutions. 
Analysis of metabolism 
The radioactive metabolites in the medium and roots of plants incubated for 12h, 24h 
and 48h with [^HJ-medicarpin were detemiined by HPLC (figures 6.2.3 a and b). In 
the growth medium the major radioactive compound was medicarpin/ 
pseudomedicarpin at all time points (figure 6.2.3a). The major medicarpin metabolite 
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Table 6.2.3a The distribution of radioactivity between roots, shoots 
and leaves in seedlings incubated with [^H-ringl-labelled medicarpin. 
Values represent the means of triplicate determination +/- standard 
deviations. 
Time(h) 
Total DPM in Each Fraction. 
Growth solution Root Extract Leaf Extract 
12 
48 
72 
3840+/-310 
5960+/-700 
1540+/-230 
8510+/-1880 
6020+/-410 
5030+/-460 
1140+/-240 
1000+/-39 
1040+/-270 
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Figure 6.2.3a Radioactive metabolites determined by H P L C in seedling 
growth solution after incubation with ['^H-ring]-labelled medicarpin for 
(i) 12h, (ii) 24h and (iii) 48h. 
After 12h 
(i) 
600 
dpm 
500 
400 
300 
200 
100 
0 
MGM 
M+ 
PM 
MP: 
i i i l i i i i i i l i i lNi i i l l l i iMIu 
500 
- c > t < ^ l ^ < J ^ o o c - ^ ^ T J u « J ^ o a c - C K ' ^ u < J ^ a a c - f t ^ t l f < J r a o c - ^ ^ t l o 
fraction number 
After 24h 
300 
200 
100 
-
M i M 
M+ 
PM 
IG 
1 MP 
iiiiiiiiuiililiii l l uiiulU lllllllll 
..(^^.^l^^^^o(JC'•o^'Sl^<J^ooc-^^^^u<J^aoc>-^^<•<Jl(<Jraoc-^M1ln 
fraction number 
(ii) 
(iii) 
800 
dpm 
600 
400 
200 
After 48h 
MGM 
ivir MP2| 
M+PM 
fraction number 
Figure 6.2.3b Radioactive metabolites determined by H P L C in the roots 
of seedlings incubated with ^H-ring labelled medicarpin for (i) 12h, (ii) 
24h and (iii) 48h as analysed by H P L C . 
Table 6.2.3b The accumulation of pseudomedicarpin in the extracts 
from the roots of seedlings, fed with [^H-ringJ-labelled medicarpin 
expressed as % radioactivity applied to T L C plate. 
% DPM Applied to T L C Plate 
Time Medicarpin Pseudomedicarpin 
12h 10% 7.6% 
24h 6.5% 12% 
48h 6.3% 11.3% 
was MP2 which remained at constant levels throughout. At 24h, some radioactive 
M G M was observed and by 48h a trace of [3H]-sativan was determined. 
In the root extracts MP2 was also observed as a minor metabolite, but unlike the cell 
cultures, [^HJ-medicarpin was largely metabolised to [^HJ-MGM (figure 6.2.3b). 
Analysis of the root extracts by TLC demonstrated that medicarpin was also being 
metabolised to pseudomedicarpin (table 6.2.3b). The analysis suggested that by 24h, 
the majority of the radioactivity eluting as medicarpin on the HPLC was in fact 
pseudomedicarpin. The rapid accumulation of pseudomedicarpin probably accounts for 
the appearance of MP2 in the cells and roots as MP2 is a metabolite of 
pseudomedicarpin. 
6.2.4 Conclusions from seedling feeding study 
Although similar evidence for the metabolism of medicarpin was obtained in the 
seedling study as had been obtained previously with cell suspension cultures, 
glucosylation in the roots appeared to be a far more major route of detoxification for 
exogenously applied medicarpin than was obtained with the cells. However, it is 
interesting to speculate that i f the experiment had been carried out for longer, or with 
older plants, such as used in the study of the allelopathic effects of medicarpin in alfalfa 
by Dornbos et al [37] that these alternative routes of metabolism may become more 
prominent. These results also demonstrated the export of medicarpin metabolites into 
the growth medium. 
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6.3 Synthesis and turnover of endogenous medicarpin in 
seedlings elicited with copper chloride 
6.3.1 Introduction 
This chapter describes a variety of experiments which aimed to investigate ways in 
which the synthesis of metabolism of medicarpin could be manipulated. Previous 
studies have reported that the synthesis medicarpin in cell cultures has been inhibited 
using AOPP [73] and with sub-herbicidal levels of the inhibitor glyphosate [79]. The 
use of such inhibitors, and pulse-chase radiolabelling techniques, suggested that it 
should be possible to selectively radiolabel the endogenous pool of medicarpin in 
elicitor-treated alfalfa plants and monitor its turnover. Previous labelling studies had 
shown that [^^Cj-phenylalanine is selectively channelled into [^^C]-medicarpin 
synthesis in elicitor-treated alfalfa cell suspension cultures [73] and the labelling studies 
of Dewick [32] suggested that such an approach would be equally effective in 
seedlings. 
As wil l be shown in the following section this was largely unsuccessful, primarily 
because as was demonstrated subsequently in alfalfa [40] and chickpea [9] the abiotic 
elicitors used to induce medicarpin accumulation cause the massive turnover of pre-
existing stores of conjugates of medicarpin and formononetin to release large amounts 
of unlabelled phytoalexins which swamp the small amount of medicarpin synthesised 
de novo. Nevertheless, the studies are worthy of inclusion as they contain some 
interesting results regarding the effects of metal salts on isoflavonoid metabolism. 
6.3.2 Objectives 
The objective of this experiment was to study the metabolism of endogenously 
produced medicarpin in seedlings treated with the abiotic elicitor copper chloride by (1) 
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labelling up the pterocarpan pools, using radiolabelled phenylalanine as substrate (2) to 
"chase" out the label, by feeding with "cold" phenylalanine or (3) to block further 
synthesis of phytoalexins using the PAL inhibitor AOPP and monitor the turnover of 
the pool. 
6.3.3 Materials and methods 
7 day old seedlings were removed from the vermiculite in which they were grown, 
washed with distilled water and their roots cut off. The petioles were then placed in 
small tubes containing 1ml solutions of 5()()|iM or 50|iM copper chloride and returned 
to their original growth conditions for 24h. Seedlings were again rinsed and placed in 
solutions each containing 1ml L-[U-^4(2]phenylalanine (1.85MBq/ml) and incubated 
for a further 24h. The treatment solutions were then changed by replacing with lOOjiM 
L-amino-oxyphenyl-propionic acid (AOPP), further incubation with L- [U-
14C]phenylalanine, or chasing out the radiolabel with 500)iM phenylalanine as 
illustrated in table 6.3.3. Al l incubations and treatments were carried out in duplicate 
and the petioles of the plants washed thoroughly in distilled water between each change 
of treatment to minimise carry-over. After harvesting, the samples were extracted and 
analysed by HPLC and scintillation counting. 
6.3.4 Results 
Analysis of the alfalfa seedlings showed, contrary to earlier studies in Durham [40] 
(section 3.1) both medicarpin and MGM levels were actually higher in seedlings treated 
with 500|iM copper chloride than those treated with 50|iM copper chloride (table 
6.3.4a). This could probably be explained by the fact that the seedlings transpired less 
than those used in previous experiments and consequently took up less copper chloride 
solution. In the seedlings treated with [U-^^cj-phenylalanine alone the concentrations 
of the isoflavonoids remained unchanged over the 72h treatment when the seedlings 
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Table 6.3.3 Treatments used to investigate the incorporation of L-[U-
l^Clphenylalanine into medicarpin during elicitation. 
Addition or Treatment at Times Shown 
Oh 24h 48h 
500uM Al l seedlings Harvested 
CuCl2 were 
washed 
and AOPP 
transferred AOPP 
to 14c 12c-phe 
phenyl- 12c-phe 
50uM alanine Harvested 
CuCl2 solution. 
72h 96h 
AOPP 
AOPP 
12c-phe 
12c-phe 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Harvested 
Table 6.3.4a Concentrations of medicarpin, MGM and F G M in alfalfa 
seedlings, treated with copper chloride followed by the various 
treatments described in table 6.3.2. 
Treat- 50p.m copper chloride SOO i^M copper chloride 
ment 
nmol/g FW nmol/g FW 
M MGM F G M M MGM F G M 
24hl4Cphe 6.9 28.7 51.5 4.1 7.2 15.5 
48hl4cphe 6.0 32.1 55.0 9.3 34.9 66.4 
Effect of phenylalanine-chase treatment 
72hl4cphe 4.8 21.5 36.2 15.5 34.8 71.9 
24hl4cphe 7.0 25.1 43.9 4.0 24.9 46.3 
24hl2cphe 
24hl4cphe 11.1 25.2 44.1 6.4 35.3 46.7 
48hl2cphe 
Values refer to the means of duplicate treatments. 
(i) 
1000 H 
Time (h) 
(ii) 
2000 H 
1000 H 
Time (h) 
Figure 6.3.4a The incorporation of L-[U-l'*C-phenylalanine into medicarpin, M G M and 
F G M after treatment with (i) 50[aM and (ii) SOOjiM copper chloride. Data points 
represent the means of duplicate determinations. 
(i) 
d p m / 
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1 0 0 -
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AOPP 
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d p m / 
nmol 
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Time (h) 
Figure 6.3.4(b) The specific activity of medicarpin in seedlings treated with (i) 
SOfjiM and (ii)500p,M copper chloride after continuing treatment with 14c 
phenylalanine, treatment with AOPP or treatment with unlabelled phenylalanine. 
Changes in treatment were initiated at 24h. Data points represent the means of 
duplicate determinations. 
14C phe nmo 
AOPP 
12C phe 
Time (h) 
(i) 
nmol 
14C phe 
AOPP 
12C phe 
Time (h) 
(ii) 
Figure 6.3.4c The speciflc activity of MGM in seedlings treated with (i) 50(iM and 
(ii)500p,M copper chloride treated cells after continuing treatment with [^'^C]-
phenylalanine, treatment with AOPP or treatment with unlabelled phenylalanine. 
Changes in treatment were initiated at 24h. Data represents the means of duplicate 
determinations. 
Table 6.3.4b The effect of AOPP on medicarpin, M G M and FGM levels 
during elicitation. 
Treatment 50|im copper chloride 5(X)|iM copper chloride 
M MGM FGM M MGM FGM 
24hWcphe 6.9 28.7 51.5 4.1 7.2 15.5 
24hl4cphe 5.1 24.0 34.6 6.7 21.5 28.6 
+24hAOPP 
24hl4cphe 2.9 17.1 20.9 23.1 10.9 13.4 
+48hAOPP 
were treated with 50\iM copper chloride, while in those treated with 500|iM copper 
chloride the concentrations of FGM, M and MGM all increased. This, again suggested 
that the lower treatment rate of abiotic elicitor had not induced changes in isoflavonoid 
metabolism (table 6.3.4a). Table 6.3.4a also illustrates that the total levels of FGM 
were considerably lower in the seedlings treated with 500fiM copper chloride when 
incubated with cold phenylalanine than in those left in the labelled solution, but again 
this is more likely to be due to natural variation as there should be no physiological 
differences between uptake of hot and cold phenylalanine. After 48h of treatment with 
AOPP, levels of medicarpin, MGM and FGM declined in seedlings elicited with 50|iM 
copper chloride (table 6.3.4b). However, after 24h of AOPP treatment, levels of all 
three compounds increased in the 500|iM copper elicited seedlings but levels were still 
lower than those observed in uninhibited seedlings. Interestingly, after 48h of AOPP 
treatment, medicarpin levels were at the highest observed throughout the course of the 
experiment, and this corresponded to a decline in levels of MGM, suggesting that the 
aglycone was being synthesised via hydrolysis of the glucoside. 
The incorporation of [^^cj.phenylalanine into medicarpin, MGM and FGM in the 
absence of any inhibitors or chasing treatments was determined by HPLC in the 
seedlings treated with 50|iM copper chloride and 500|iM copper chloride (figure 
6.3.4a). With both elicitor treatments incorporation into the isoflavonoids was in the 
order FGM>MGM>medicarpin. This was in contrast to elicitor treated cell cultures 
which showed an order of incorporation of medicarpin>MGM>FGM [73]. 
Interestingly, although overall levels of these isoflavonoids were lower in the plants 
treated with 50|iM copper chloride than with the 500|iM treatment the rates of 
incorporation of the [^ ^cj-phenylalanine into all three isoflavonoids was more rapid. 
The specific activity of medicarpin in the 5())iM copper elicitation study, illustrated in 
figure 6.3.4b(i) displayed little significant difference in the extracts from AOPP-
inhibited and uninhibited treatments. However, in the 500|J.M copper treated seedlings, 
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after 24h of AOPP treatment the specific activity of medicarpin was significantly lower 
than in the uninhibited seedlings, showing that biosynthesis of medicarpin through the 
phenylpropanoid pathway had been successfully inhibited. Since after 24h, the specific 
activity of MGM had declined, this would suggest that the medicarpin at this point in 
time was being made available by hydrolysis of the glucoside. The results are harder to 
interpret after 48h of AOPP treatment. The specific activity of medicarpin declined 
(figure 6.3.4b(ii)), although total levels had risen from 6.7nmol at 24h (table 6.3.4b) to 
21.7nmol. The corresponding drop in MGM levels again suggested medicarpin was 
coming from preformed stores of glucoside. However, the sharp increase in the 
specific activity of MGM illustrated in figure 6.3.4c, which indicated that the preformed 
M G M was in a separate pool to the newly synthesised radiolabelled MGM and it is this 
pool that was being utilised as a source of phytoalexin. 
6.3.5 Conclusion 
The [3H-ring]-labelled medicarpin which was fed to alfalfa seedlings demonstrated that 
metabolism of exogenously applied medicarpin to seedlings was similar to that found in 
alfalfa cell suspension cultures, with the exception that greater levels of MGM were 
synthesised in the seedlings. Attempts to label endogenous phytoalexins were 
unsuccessful due to the effects of copper chloride elicitation on conjugate turnover. 
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The effects of inhibitors on the metabolism of 
medicarpin in alfalfa cell cultures 
7.1 Introduction 
The pathways of metabolism of medicarpin discussed in the previous chapters involve 
primarily further methylation and/or hydroxylation of the phytoalexin. A range of 
inhibitors are available for the specific inhibition of these enzymes, for example S-
adenosyl methionine dependent methyltransferases can be competitively inhibited with 
sinefungin or tubericidin [63, 129], while the inhibitor aminobenzotriazole can 
suppress monooxygenase activities [20]. These inhibitors of methylation reactions and 
cytochrome P450 mediated hydroxylations were, therefore, potentially useful in 
studying the sequence of biotransformation reactions involved in medicarpin 
metabolism. In addition, the earlier studies had suggested that medicarpin may be 
selectively transported across the plasmamembrane and several inhibitors of active 
transport were assessed for their ability to disrupt this movement. 
7.2 The inhibition of the further metabolism of medicarpin 
7.2.1 Objectives 
The objectives of this experiment were to selectively inhibit the further metabolism of 
medicarpin with the use of methylation inhibitors sinefungin, tubericidin and 
cycloleucine and the monooxygenase inhibitor aminobenzotriazole. This was in order 
to study the regulation of metabolism of medicarpin by monitoring whether the 
phytoalexin could be channelled in to other routes of metabolism upon the inhibition of 
the pathways previously demonstrated. 
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7.2.2 Materials and methods 
Sinefungin, tubericidin, cycloleucine or aminobenzotriazole were added to 3ml cell 
culture of 7 day old alfalfa cells (variety Vela) to a final concentration of 0.2mM and 
incubated on a shaker for 6h. 75nmol of [^HringJ-labelled niedicarpin with a specific 
activity of 345dpm/nmol (6Bq/nmol) were added and the cells were incubated for a 
further 4h. The cells and media were separated and extracted as described (chapter 2) 
and were analysed by H P L C , T L C and scintillation counting. Controls were included 
which contained no inhibitors. 
7.2.3 Results 
The total amount of radioactivity remaining incorporated in medicarpin and 
pseudomedicarpin in combination was analysed by T L C and is illustrated in figure 
7.2.3. The figure demonstrates that in the absence of any inhibitor a higher level of 
radiolabelled medicarpin was metabolised than in the presence of any of the inhibitor 
treatments used. However, none of the inhibitors had a major effect on the metabolism 
of [^Hj-medicarpin to pseudomedicarpin, vestitol, sativan, or variabilin. A minor, but 
significant reduction in the synthesis of pseudomedicarpin was observed in the 
presence of aminobenzotriazole, but not in the presence of methylation inhibitors. 
Since these metabolites appear to be derived from hydroxylations and methylation of 
medicarpin the failure of any of the inhibitors to significantly reduce their synthesis 
suggested that the reduction in overall metabolism may have been caused by pleiotropic 
effects rather than selective inhibition. 
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Figure 7.2.3 Concentrations of ['^H-ring]-labeIled medicarpin and 
radioactive metabolites in cell cultures treated with inhibitors of 
methjlation (tubericidin, cylcoleucine, sinefungin) and hydroxylation 
(aminobenzotriazole) reactions. 
7.3 Studies on the export of medicarpin from cells and 
seedlings. 
7.3.1 Introduction 
In plants, the plasmamembrane ATPase differs markedly from the mitochondrial 
ATPase in many of its kinetic properties such as affinity for ATP, nucleotide 
specificity, divalent cation specificity and pH optimum. It also differs in sensitivity to 
inhibitors, being uninhibited by the classical inhibitors of mitochondrial ATPases such 
as oligomycin, venturicidin and azide, but is extremely sensitive to vanadate. DCCD is 
the classical inhibitor of the F Q (H"*" conducting) portion of mitochondrial, chloroplast 
and bacterial ATPases, whereas vanadate is more specific to plasma membrane 
ATPase. Although little is known about the export/ import mechanisms of secondary 
compounds in general, including phytoalexins, it can be seen that in alfalfa the 
extracellular media is used as a major, temporary sink for the short term storage of 
medicarpin while it is being further metabolised in the cell cultures. 
7.3.2 Objectives 
The objectives of the following experiments were several fold. It was hoped primarily 
to ascertain whether the export of medicarpin in alfalfa cell cultures could be inhibited 
by using ATPase specific inhibitors. This would indicate whether the transport 
processes involved are active or passive. If this could be achieved it was hoped to try 
and inhibit elicited plant cells from exporting the medicarpin into the extracellular sink, 
and see i f the phytoalexin could be channelled through routes of metabolism additional 
to glucosylation. 
104 
7.3.3 IMaterials and methods 
50ml lOday old cell suspension cultures (variety Europe) were pre-treated with the 
ATPase inhibitor DCCD to a final concentration of O.lmM or O.OlmM for thirty 
minutes before treating +/- elicitor. Controls were included with elicitor only, DCCD 
only and where the cells were pre-treated with elicitor for 30 minutes and then treated 
with DCCD. Media and cells were separated, extracted and analysed for isoflavonoids 
by HPLC and TLC as described previously. The experiment was then repeated over a 
20h time course, in the presence and absence of PAL elicitor AOPP (O.lmM). 26 
flasks of alfalfa cell cultures were elicited and 8 control flasks were also established. 
After four hours, two control flasks and two elicited were harvested. Two flasks were 
treated with O.lmM DCCD, two were treated with AOPP and DCCD and two were 
treated with AOPP only. These treatments were repeated at eight and sixteen hours 
after the point of elicitation and at each time point the cells were incubated with the 
elicitors for a further four hours. 
7.3.4 Results 
As determined from the relative HPLC elution profiles, there appeared to be a marked 
difference in the levels of ethy! acetate ex tractable compounds present in the media 
when DCCD was added to the cells (figure 7.3.4a). However, the concentrations of 
medicarpin and formononetin were similar in the presence and absence of DCCD 
(figure 7.3.4b), though a greater proportion of the phytoalexin was found in the media 
in the presence of the inhibitor. Interpretation of the effects of the inhibitor were 
complicated by the fact that in the absence of elicitor DCCD could also elicit phytoalexin 
production (figure 7.3.4c). Initial, quantitative analysis of media extracts alone 
suggested that the DCCD had successfully inhibited medicarpin export, but more 
careful analysis demonstrated that when the DCCD and elicitor were both present in a 
single treatment, they had antagonistic effects upon the elicitation of medicarpin. PAL 
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Table 7.3.4 P A L activity in alfalfa cell cultures treated with elicitor 
and/or D C C D for 4h 
Treatment PAL activity (^ikat) 
O.IMDCCD 4.891 +/- 0.531 
eUcitor 2.270 +/- 0.619 
eUcitor + O.IM DCCD 3.893 +/- 0.900 
elicitor + 0.01 M DCCD 2.740 +/- 0.174 
O.IMDCCD + elicitor 1.616 +/- 0.551 
Values refer to means of duplicate determinations +/- the variation in the replicates. 
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-DCCD medicaipin 
o.ooaM 
fojmiononimn 
'J.oa iaLoo 5 D 1 « 3BI5O aa^ .oo' w'.w ' « ! » 9;«o 
—fcSBT +DCCD formononetin 
D.oiira-r 
O.COEO-1 
(ii) 
meaicaipin 
^ • • i o ' . « "iSo'-oo « l w 30-^ 0 i^ '.o^ ^ 
—fiUT 
Figure 7.3.4a HPLC analysis of media extracts of elicitor-
treated alfalfa cell suspension cultures treated-vith or without 
DCCD. 
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Figure 7.3.4b Levels of formononetin and medicarpin in the media of 
elicited and DCCD treated cells, as analysed by H P L C . Data represents 
the mean of duplicate determinations with error bars showing variation 
in the replicates. 
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Figure 7.3.4c HPLC analysis of media extract of unelicited 
cell suspension cultures treated vith DCCD. 
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Figure 7.3.4d HPLC analysis of media extracts of elicited 
alfalfa cells treated vith or without vanadate. 
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Figure 7.3.4e Distribution of medicarpin between cells and media in 
elicited cells treated for 4h (i) without DCCD and (ii) with DCCD. 
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Figure 7.3.4e The distribution of medicarpin between cells and media 
in elicited cells treated for 4h with (iii) AOPP and (iv) D C C D and 
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assays carried out on the cells also indicated that elicitation was greatest in cells treated 
with DCCD and no elicitor, with levels being lowest in those treatments which had both 
DCCD and elicitor present (table 7.3.4). 
An additional ATPase inhibitor, sodium orthovanadate (0.1 mM) was also used to 
detennine the effect on the distribution of medicarpin in ehcitor culture. Figure 7.3.4d 
Dlustrates that there was no significant difference in the concentrations and profile of 
secondary compounds in the media of cells treated with elicitor and orthovanadate and 
those just treated with elicitor. In fact the two HPLC traces can easily be superimposed 
with little overlap between the two chromatograms. 
The second experiment using DCCD was designed to try and clarify the effects of the 
inhibitor on medicarpin transport. The PAL inhibitor AOPP was used 4h after 
elicitation in a parallel study, with and without DCCD to try and minimise the elicitation 
effects caused by the ATPase inhibitor and also to investigate the importance of 
preformed phytoanticipins in the early stages of elicitation, by blocking de novo 
synthesis of medicarpin. Figure 7.3.4e illustrate the effects of these treatments on the 
levels and distribution of medicarpin. The levels quoted in the cells are inclusive of 
both the aglycone and MGM. Comparing first the graph of elicited cells to that of 
elicited and DCCD treated cells (figures 7.3.4e(i) and (ii)), it can again be seen that total 
levels of medicarpin were slightly lower in those cells which had been subjected to both 
treatments. However, there appeared to be litUe significant difference in distribution of 
medicarpin in the cells and media between those cells treated with or without DCCD. 
Figure 7.3.4e(iii) illustrates the effects of AOPP treatment at different points in the time 
course. Here it is worth pointing out as described in the methods section AOPP was 
added for 4h at each point in the time course, so it should have been the point at which 
medicarpin was most actively being synthesised de novo that AOPP would have the 
most noticeable effects. It can cleariy be seen that there was a major difference in 
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medicarpin levels between those cells treated with elicitor and AOPP and those just 
treated with elicitor. The time points shown on the graph are the times at which the 
cells were harvested and extracted so the AOPP had been added 4h prior to each time 
point illustrated. The time at which the AOPP was added is taken to be the time at 
which de novo medicarpin synthesis was successfully inhibited. Thus it can clearly be 
seen that the effects of AOPP were not noticeable 4h after elicitation had begun, but 
were very significant at 8 and even at 16h after the onset of elicitation. This confirms 
the suggestions made in section 6.3 that much of the medicarpin produced in the first 
few hours of the elicitation response comes from preformed stores (MGM) rather than 
being synthesised de novo. However, after four hours and up to at least sixteen hours 
after elicitation the vast majority of the medicarpin was being synthesised via the 
phenylpropanoid pathway. 
Comparing those elicited cells treated with AOPP alone and those treated with AOPP 
and DCCD, there does appear to be a difference in distribution of medicarpin between 
the cells and media. This is most marked at 12h where there is little medicarpin present 
in the cells because synthesis has been inhibited by the AOPP, but the medicarpin in the 
media has not re-entered the cells which were treated with DCCD. This suggests that 
maybe it is the re-import of medicarpin that is the ATPase dependent step, where the 
phytoalexin is taken up into the cells at a pace it can be further metabolised by the routes 
discussed in previous chapters. 
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Chapter 8 
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Discussion 
The aim of this dissertation has been to investigate the metabolism of medicarpin in 
both elicitor-treated and unelicited cell cultures and also in alfalfa seedlings. Therefore, 
taking first the cell cultures, the work started by optimising the conditions under which 
the accumulation of the phytoalexin medicarpin was induced, by manipulating 
parameters such as the type and dose of elicitor and the timing and length of elicitor 
treatment. The increase in the specific activity of the enzyme PAL was also 
demonstrated, to confirm that the elicitors were activating de novo phenolic 
metabolism. Analysis of media and cell extracts throughout the same time course 
confirmed that medicarpin was the major elicited compound in alfalfa cell cultures and 
that much of this phytoalexin was quickly exported into the media being clearly visible 
only two hours after the onset of elicitation. 
The elicitor-treated cell cultures were then fed with [U-^^cj-phenylalanine, [^H]-
phenylalanine or [^H-methylj-methionine and the phytoalexin labelled respectively as 
[l^C-benzylJ-medicarpin, [^H-benzylJ-medicarpin and [^H-methylJ-medicarpin 
isolated and purified by TLC and HPLC. The labelling studies with [ l ^C] - and pH]-
phenylalanine confirmed that medicarpin was a major radiolabelled extractable product 
in elicitor-treated alfalfa cell cultures. Similarly the formation of radioactive MGM 
confirmed that some of the de novo synthesised medicarpin was being immediately 
conjugated, in agreement with Kessman et al [73]. In contrast, the efficient labelling of 
medicarpin with [^H-methylj-methionine was less expected and suggested that after 
cycloheximide treatment the methylating capacity of the cells was being selectively 
directed into the synthesis of phytoalexins. Recent studies by the research group at 
Durham have confirmed that the increased methylating capacity observed in elicitor-
treated alfalfa is predominantly channelled into the synthesis of medicarpin and related 
compounds [41]. As will be discussed later the stage in medicarpin synthesis at which 
methylation occurs is still unclear, but the results of the [3H-methyl]-methionine 
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labelling study suggest that this is the procedure of choice i f medicarpin of high specific 
activity is required. 
Whilst purifying this radiolabelled phytoalexin, it was observed that, although it was 
collected as one peak from HPLC, two closely migrating peaks were observed when 
analysed by TLC, the second compound, which also had pterocarpan characteristics 
was named "pseudomedicarpin." Subsequent studies in which medicarpin was fed to 
elicited and unelicited cell cultures showed that pseudomedicarpin was a major 
metabolite of medicarpin and the conversion of medicarpin to pseudomedicarpin could 
be shown to occur in a time dependent manner in cells fed with the phytoalexin. Mass 
spectral analysis suggested that pseudomedicarpin was a hydroxylated derivative of 
medicarpin (figure 8) though having ascertained that the hydroxy group was not present 
in the 6a position the actual placing of the hydroxy group was not possible to 
determine. The determination and partial characterisation of pseudomedicarpin as a 
metabolite, and potential contaminant of medicarpin in alfalfa is significant. Thus, 
HPLC is commonly used to quantify medicarpin accumulation in alfalfa [24] but the 
presence of contaminating pseudomedicarpin would suggest that such determinations 
would over-estimate the true concentrations of the phytoalexins. Furthermore, it is 
unclear whether the biological activity associated with medicarpin isolated from cell 
cultures by HPLC is due to medicarpin or pseudomedicarpin [13]. Interestingly, 
hydrolysis of the isoflavonoid conjugates present in both roots and cells failed to 
demonstrate the presence of glycosylated pseudomedicarpin, suggesting that the 
compound was a poor substrate for the respective o-glucosyl transferase in alfalfa 
[100]. 
Feeding studies with the variously labelled preparations of medicaipin demonstrated 
that both alfalfa plants and cell cultures were able to metabolise the phytoalexin to 
multiple metabolites. As suggested in the earlier studies with [14c]-phenylalanine, 
glucosylation and 6"-0-malonylation of medicaipin to yield MGM was a significant 
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Figure 8 The five routes of metabolism identified in alfalfa. Reaction 1 shows the 
reversible synthesis of medicarpin 7-0-giucoside-6"-0-malonate, 2 demonstrates the hydroxylation ol 
medicarpin to pseudomedicarpin and the further metabolism of this compound to the 
unstable metabolite MP2.3 illustrates the demethylation of medicarpin and 
the formation of a demthylated product MP3. 4 shows the ring opening and 
hydroxylkation to form the isoflavan vestitol and the subsequent methylation giving rise 
to sativan. Finally the fifth pathway shown illustrates the hydroxylation and methylation 
via an unknown intermediate to form variabilin (homopisatin). 
route of medicarpin metabolism in the roots of seedlings and to a lesser extent in cell 
cultures (figure 8). The recent studies of Parry et al have shown that the synthesis and 
turnover of M G M in alfalfa is a dynamic process and therefore MGM cannot be 
considered as an end-point of metabolism. Rather, as this project has demonstrated 
there are multiple alternative routes of detoxification present in both unelicited and 
elicitor-treated alfalfa. The chemical structures of the other compounds identified as 
medicarpin metabolites are shown in figure 8. Significantly, MP4 and MP7 were 
identified as the isoflavans vestitol and sativan respectively. These isoflavans have 
been shown to accumulate in alfalfa plants before, but have not been reported in alfalfa, 
cell cultures. The metabolism of medicarpin to isoflavans may be important in reducing 
the phytotoxicity of the phytoalexins produced in alfalfa. In studies concerning the 
allelopathic effects of medicarpin on alfalfa seedlings, Dombos et al [37] carried out 
dose toxicity studies with medicarpin, 4-methoxymedicarpin, sativan and 4-
methoxysativan. When applied exogenously in agar bioassays they found that seedling 
growth of alfalfa and velvet leaf {Abutilon theophrasti ) was inhibited when medicarpin 
was applied and that the minimum toxic dose of medicarpin was approximately 5x 10"^ 
mol/seed. At doses greater than this minimum dose they observed a linear relationship 
between increased medicarpin concentration and reduced seedling length. However, 
the seedling growth of alfalfa and velvet leaf was not inhibited by 4-methoxy 
medicarpin, sativan and 5'methoxysativan, thus suggesting that the metabolism of 
medicarpin to sativan is indeed a detoxification route. The ability to convert medicarpin 
to isoflavans is not confined to plants and the fungus Stemphylium botyrosum, which 
is pathogenic to alfalfa can reduce medicarpin to vestitol. An interesting point to 
investigate in the future would be to study the differential toxicities of vestitol and 
medicarpin to pathogenic fungi of alfalfa, as i f vestitol and sativan were as toxic to 
fungi as medicarpin it may be of interest to up regulate the synthesis of the isoflavans at 
the expense of medicarpin so that alfalfa could maintain the fungitoxicity of the 
phytoalexin, while reducing autotoxicity. Such a strategy would necessitate the 
identification of enzyme(s) involved in converting the pterocarpans to isoflavans. 
I l l 
Dewick and Martin investigated the interrelationships between pterocarpans and 
2'hydroxyisoflavans using radiolabelled precursors in copper chloride treated seedlings 
[33]. They showed that [U-l'^C]-phenylalanine was maximally incorporated into 
vestitol after 6h and into sativan after 12h. They also found that labelled medicarpin 
could be incorporated into vestitol and sativan and that vestitol could be incorporated 
into both medicarpin and sativan. From these studies they concluded that medicarpin 
and vestitol may be inter convertible, but postulated that it was more likely that in vivo 
they are synthesised simultaneously via a common intermediate, this intermediate 
perhaps being a carbonium ion. They also concluded that sativan probably derives 
from the methylation of vestitol as shown in figure 8. 
The synthesis of isoflavans in alfalfa cell cultures is somewhat contentious. In earlier 
studies with callus lines of alfalfa infected with Verticillium albo-atrum Latunde-Dada 
and Lucas [79] found little evidence for the production of sativan in the callus lines 
used, as compared with stem sections of alfalfa challenged with culture filtrates of 
Verticillium albo-atrum. Gustine and Moyer [52] suggested that the absence of 
phytoalexins sativan and vestitol in abiotically elicited callus cultures suggested that 
some phytoalexin anabolic pathways contain metabolic blocks in cells of cultured 
tissue. In our studies, without the use of radioactivity to increase the sensitivity of the 
detection of metabolites, it would have been virtually impossible to target the 
purification of metabolites as they were represented by very minor UV absorbing peaks 
when analysed by HPLC and TLC. However, the presence of the isoflavans 
confirmed that in the cell lines and conditions used for this work, no metabolic block in 
isoflavan synthesis was present, but that the synthesis of these compounds was much 
reduced compared with elicited whole plant tissue. 
The demethylated product MP3 observed in our studies was never structurally 
characterised. However, demethylation of niedicarpin would be an expected route and 
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demethylmedicarpin was a metabolite of medicarpin when white clover (Jrifolium 
repens )leaflets were inoculated with a spore suspension of Moniliniafructicola [133]. 
MPS, which was subsequently identified as variabilin (also known as homopisatin) has 
been reported in fungally infected red clover (Jrifolium pratense ) [12]. Variabilin is 
reportedly antifungal, although the more major fungal derivative of medicarpin was 
found to be 6a-hydroxymedicarpin. Significantly, in our metabolism studies no 
intermediate was found between medicarpin and variabilin and it was not possible to 
determine the order of 3-0-methylation and 6a-hydroxylation. Methyl transferase 
assays were carried out using niedicarpin as a substrate (data not shown) and 
demonstrated negligible incorporation of [l^C-methylJ-groups from S-adenosyl-L-
[14c-methyl]-methionine, suggesting that 6a-hydroxymedicarpin may be the true 
substrate, but as this compound was unavailable it was not possible to determine 
whether it was a better substrate for 3-0-methylation. Also, the methylation and 
monooxygenase inhibitor studies described in Chapter 7 did not selectively inhibit the 
further metabolism of medicarpin, as they had been hoped to selectively inhibit the 
conversion of medicarpin to variabilin and lead to the accumulation of an identifiable 
intermediate thus providing evidence for the route of metabolism. 
In the studies carried out by Edwards and Dixon [38] the major elicitor-inducible 
isoflavone-O-methyl transferase in alfalfa was shown to be a 7-0-methyl transferase, 
which also showed activity towards pterocarpan substrates. It is possible, therefore, 
that this elicited methyl transferase is involved in the synthesis of variabilin and related 
metabolites. The involvement of this enzyme in medicarpin metabolism is of future 
interest, however, it is worth pointing out that i f this enzyme is responsible for the 
methylation of medicarpin products in alfalfa it was reported as being maximally 
induced 12 hours after elicitation and also that it was induced 200 fold within this time 
period, yet, extensive feeding studies with labelled medicarpin, in elicited and unelicited 
cell suspension cultures, showed little difference in patterns of metabolism. This 
observation casts some doubt on its role in variabilin synthesis and in future studies it 
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wil l be of interest to determine the relationship between the 7-0-methyl transferase and 
medicarpin metabolism in greater detail. 
The identity of the remaining metabolites of medicarpin is intriguing. The formation of 
MP2 in cell cultures fed with either medicarpin or pseudomedicarpin suggests that it is a 
metabolite of pseudomedicarpin. The characterisation of MP2 would be a major 
objective of any future work as it is an appreciable product of the phytoalexin in both 
plants and cell cultures. The major difficulties encountered in isolating enough MPl , 
MP2, MP3 and MP6 for structural characterisation related to the relatively small 
amounts of these compounds accumulating in eluted cultures, the difficulty of resolving 
these metabolites from other polar compounds and, in particular, their labile nature. In 
future studies it may be preferable to derivatize these compounds with diazomethane or 
other alkylating agents and thus reduce their potential for oxidation/ degradation and 
making them easier to resolve from other cellular components. 
Another aspect of medicarpin metabolism which warrants further study concerns the 
further metabolism of the medicarpin metabolites (MPs 1-8). The studies described in 
this programme have only elucidated some of the primary metabolites of the 
phytoalexin, with the suggestion that further degradation to multiple metabolites then 
occurs. This multiplicity of detoxification products presumably accounts for the 
dramatic disappearance of the major UV-absorbing fraction corresponding to 
medicarpin in extracts from cell cultures 12-24h after elicitor treatment as determined by 
HPLC. The [14c02] capture experiment did suggest that some medicarpin could be 
entirely mineralised. However, the lack of incorporation of radiolabel into the insoluble 
fraction following any of the feeding studies with radioactive medicarpin suggested that 
those parts of the phytoalexin labelled with radioisotopes were not being incorporated 
into the cell wall or polymerised into insoluble matrices. This is in contrast to the work 
of Barz et al [10] who suggested that isoflavonoids are removed from solution by 
polymerisation following the action of extracellular peroxidases. Our studies would 
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suggest that all the primary metabolism of medicarpin occurs within the cells and the 
peroxidases found in the cell extracts, cell wall and medium have no activity towards 
the phytoalexin. However, the probability that the degradation products of medicarpin 
can serve as substrates for extracellular polymerisation does warrant further study. 
A notable effect of using extracellulariy applied medicarpin was the fact that even 12 
hours after addition, significant amounts of the phytoalexin remained untransformed, 
perhaps suggesting that the medicarpin could be entering different metabolic pools to 
the medicarpin which was synthesised within the cells which is metabolised very 
rapidly. An attempt was made to monitor the metabolism of endogenously produced 
medicarpin following the labelling of phytoalexin pools in the roots of seedlings treated 
with copper chloride. Unfortunately, the massive turnover of the conjugates of 
medicarpin and its precursor fomiononetin which are induced by treating alfalfa plants 
with copper chloride, made it impossible to follow the metabolism of the relatively 
small pool of de novo synthesised radiolabelled medicarpin. One possible approach to 
study the endogenous metabolism of medicarpin and the turnover of the MGM pool 
would be to radiolabel the pool of conjugate in unelicited cells then treat the cells with 
elicitor in the presence of AOPP. Under these conditions radiolabelled medicarpin 
would be released form the conjugate pool as a phytoanticipin, while the AOPP 
treatment would prevent the further synthesis of medicarpin complicating the analysis. 
The metabolism of the endogenous medicarpin could then be followed in the elicited 
cells. Such an approach would necessitate the selective radiolabelling of the MGM pool 
and it would probably be necessary to use [^^C]- or [^Hj-labelled chalcone or 
isoflavone precursors, such as those used by Dewick [30] to obtain radioactive MGM 
of high enough specific activity. Similady, it may be also possible to study the 
metabolism of de novo synthesis using more specific radiolabelled precursors. 
As described in Chapter 7, within the time available attempts to manipulate the further 
metabolism of medicarpin by selective inhibition were unsuccessful, as were attempts 
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to selectively inhibit the export of phytoalexins from the cells. As some of the 
inhibitors used elicited medicarpin production it was difficult to assess the results 
without using radiolabelled phytoalexins. Future studies would concentrate on the 
effects of the ATPase inhibitor DCCD on the import of [^H]- or [^^Q- medicarpin into 
the cells to ascertain whether uptake was active or passive. 
In summary, the further metabolism of medicarpin was shown to follow at least 5 
distinct routes (figure 8), and proved to be a far more complex process than had first 
been anticipated. The elucidation of such routes of metabolism and the identification of 
the enzymes involved may present a novel strategy for controlling the phytoalexin 
response in legumes. Thus the way in which plants accumulate phytoalexins could be 
modified through the genetic engineering of the respecrive genes to favour the synthesis 
of phytoalexin metabolites which are antifungal but of reduced autotoxicity. 
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